TSS:Hg 44043.1

Basic information about the TSS

---

TSS ID: hg_44043.1 Species: human Chr: chr3		Start: 120094284 End: 120094305 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC012760 Distance: -112 GeneID: 2932 HGNC/MGI_ID: HGNC:4617 UniProt_ID:

Gene_name: glycogen synthase kinase 3 beta Gene_symbol: GSK3B Gene_synonyms: Gene_source: HGNC:4617

TATA-Box annotation

---

Distance to TSS:	152
Nearest PromoterID:	NM_001354596
Entrez ID:	2932
Nearest Unigene:	Hs.445733
Nearest Refseq:	NM_002093
Nearest Ensembl:	ENSG00000082701
Gene Name:	glycogen synthase kinase 3 beta
Gene Alias:	-
Gene Description:	glycogen synthase kinase 3 beta
Gene Type:	protein-coding
CpG%:	0.115
GC%:	0.751244
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GSK3B p2@GSK3B p3@GSK3B p4@GSK3B p5@GSK3B p6@GSK3B p7@GSK3B p9@GSK3B p10@GSK3B
Sample		p1@GSK3B	p2@GSK3B	p3@GSK3B	p4@GSK3B	p5@GSK3B	p6@GSK3B	p7@GSK3B	p9@GSK3B	p10@GSK3B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	29.80	2.73	1.17	0.97	1.95	1.36	0.97	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	28.12	2.43	1.01	0.61	2.63	0.61	0.20	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	29.13	1.93	1.35	0.96	3.09	1.16	1.16	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.29	1.66	0.21	0.62	2.91	1.04	0.83	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	27.00	2.02	1.35	0.67	3.60	1.12	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	25.39	1.74	1.16	0.78	2.52	0.39	0.78	0.00	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	28.54	3.27	0.87	1.09	3.70	1.31	0.65	0.00	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	21.07	1.70	0.48	0.97	3.63	1.21	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	26.50	1.28	0.21	1.07	2.78	0.43	0.64	0.21	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.03	1.74	3.48	1.16	1.16	0.00	1.16	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	23.45	2.83	2.02	0.40	1.21	0.40	0.00	0.00	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.73	1.63	1.22	0.41	4.07	0.81	0.81	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.50	6.13	0.32	1.77	0.16	0.48	1.13	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	21.80	2.86	0.15	1.05	0.30	0.60	0.45	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.71	2.85	0.00	1.54	0.22	0.44	0.44	0.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.10	2.77	0.50	1.01	0.00	0.25	1.26	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.51	3.93	0.22	1.31	0.00	0.44	0.87	0.00	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	12.23	4.64	0.00	0.84	0.00	0.42	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.99	3.73	1.07	0.53	0.00	0.53	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.85	2.56	0.45	1.65	0.45	0.30	0.90	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	19.65	3.61	0.00	0.67	0.00	0.27	0.94	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	17.61	2.07	0.35	1.21	0.00	0.69	0.69	0.00	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.25	4.14	0.13	0.90	0.26	0.39	0.39	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.05	3.15	0.24	2.43	0.24	0.24	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.77	2.58	0.26	1.81	0.00	0.52	0.52	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.83	2.53	0.00	0.95	0.32	0.63	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.33	2.75	0.00	2.20	0.00	1.65	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	26.17	4.01	0.47	1.41	0.71	0.71	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.96	2.58	0.00	1.62	0.32	0.65	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	17.73	3.80	0.36	1.09	0.54	0.18	0.18	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	20.93	3.77	0.21	0.42	0.42	0.00	0.63	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.83	3.71	0.20	0.98	0.00	0.20	0.78	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.05	4.85	0.00	0.63	0.21	0.21	1.06	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.78	4.45	0.49	1.15	0.49	0.99	0.82	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.02	3.55	0.00	1.68	0.37	0.00	0.56	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.59	2.30	0.00	0.38	0.00	0.38	0.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.66	3.47	0.20	1.43	0.41	0.82	0.41	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	18.54	3.43	0.20	1.01	0.00	0.20	0.40	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.94	2.16	0.00	1.35	0.54	0.54	0.00	0.00	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.44	3.36	0.96	0.24	0.24	0.72	0.96	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	19.29	1.88	0.47	0.71	0.47	0.71	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	21.81	3.07	0.44	1.17	0.00	0.59	1.17	0.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.82	2.74	0.21	0.63	0.21	0.42	1.05	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.51	2.80	0.17	0.87	0.35	0.17	0.52	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	17.27	3.41	0.40	1.20	0.20	0.60	0.60	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.52	1.86	0.00	2.33	0.00	0.47	0.23	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.47	2.64	0.72	1.44	0.00	0.48	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.29	3.87	0.30	0.60	0.00	0.30	1.49	0.00	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.17	5.27	0.48	0.48	0.48	0.48	0.72	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	19.61	3.84	0.81	0.20	0.20	0.81	1.01	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	13.94	2.87	0.00	0.41	0.20	0.61	0.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.68	2.45	0.00	1.11	0.44	0.22	0.89	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.55	4.61	0.71	1.06	0.35	0.35	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.54	3.98	0.33	1.33	0.33	0.99	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.85	0.84	0.00	1.68	0.00	1.68	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	18.37	1.84	0.00	1.38	0.00	0.46	0.00	0.00	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.64	2.59	0.00	0.32	0.32	0.00	1.62	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.56	2.89	0.00	2.25	0.00	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.86	1.89	0.63	1.57	1.26	0.94	0.31	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.74	3.53	0.71	2.82	0.00	0.00	0.00	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	4.49	0.56	0.56	0.56	0.00	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	28.66	0.80	0.00	1.59	1.59	1.59	0.00	0.00	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.91	1.02	0.34	0.00	0.34	0.34	1.36	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.12	2.27	0.32	1.30	0.00	0.32	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.49	4.26	1.77	0.35	0.00	0.35	0.35	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	7.90	0.00	0.00	7.90	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	16.09	1.95	0.49	0.98	0.00	0.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.37	3.47	0.00	0.50	0.00	0.00	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.67	2.35	0.00	0.94	0.00	0.47	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.58	2.65	0.00	0.33	0.66	0.33	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.97	1.55	0.00	0.31	0.00	0.31	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.56	3.06	0.00	2.14	0.61	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	13.46	4.43	0.48	1.43	0.48	1.11	0.48	0.16	0.79
Adipocyte - breast, donor2	11327-117E4	26.31	4.97	0.80	1.12	0.80	1.93	0.00	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	24.43	6.36	0.64	2.16	0.38	1.78	0.25	0.13	0.51
Adipocyte - omental, donor2	11474-119C7	8.22	4.48	0.75	0.00	0.00	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	13.06	5.02	1.00	1.00	0.00	0.00	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	10.21	2.55	0.00	0.64	1.28	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	4.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	0.45	0.45	2.26	0.45	0.90	0.00	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	14.94	1.39	0.00	0.70	0.00	1.22	0.35	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	15.45	3.91	0.78	1.17	0.59	0.98	3.13	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	10.30	3.60	0.77	2.06	1.03	2.06	1.54	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	17.84	4.46	0.28	1.67	1.39	0.84	1.12	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	25.86	7.05	2.94	1.18	0.00	1.18	1.18	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	25.10	4.34	1.29	1.77	1.77	1.45	2.98	0.08	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	16.46	5.49	0.00	1.61	0.97	0.32	2.58	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	16.00	4.27	0.00	1.60	1.07	0.53	2.67	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	29.49	5.01	0.56	1.67	0.00	1.67	1.11	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	25.79	2.50	0.83	2.08	1.25	0.83	1.66	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	10.80	3.01	0.50	1.26	1.76	0.75	0.75	0.50	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	16.69	2.95	0.65	1.96	0.33	0.65	0.65	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	27.71	2.13	0.00	2.13	0.61	0.91	2.44	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	17.68	3.09	0.66	0.44	0.22	0.66	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	6.81	0.72	0.00	0.36	0.36	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	18.17	4.86	0.72	2.16	1.62	1.44	0.18	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	5.02	0.00	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	23.63	5.14	0.62	0.41	0.82	2.05	0.21	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	14.76	5.61	0.11	1.37	0.11	0.46	0.34	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	11.27	2.69	0.00	0.98	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.33	2.25	0.45	2.25	0.45	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.29	1.30	1.30	2.17	1.30	0.87	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	4.28	2.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.85	1.79	0.90	0.60	0.30	0.30	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	3.79	1.26	0.00	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	0.66	0.66	1.98	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.37	1.95	0.32	0.97	0.65	0.65	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.08	0.97	0.49	1.46	0.49	0.97	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.28	1.78	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.07	1.51	0.38	0.38	0.00	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.96	3.63	0.73	0.00	0.73	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	2.51	0.00	1.25	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.49	3.29	1.15	1.65	0.49	0.66	0.00	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	1.36	1.36	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.75	3.17	0.30	1.06	0.45	0.30	0.15	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.72	1.61	0.54	1.61	0.00	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.98	1.51	0.38	0.57	0.19	0.38	0.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.42	4.28	0.27	1.34	0.53	0.80	0.27	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	1.95	0.00	0.00	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	12.44	3.32	1.16	0.50	0.00	0.17	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	1.20	0.00	0.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.12	2.40	0.34	1.37	0.34	0.34	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	2.43	0.97	0.00	0.49	0.00	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.04	3.04	0.38	1.14	0.00	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	6.06	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	0.57	1.71	0.00	0.57	0.57	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.19	1.92	1.28	0.43	0.00	0.43	0.00	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.13	1.81	0.52	0.26	0.00	0.77	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.45	3.75	0.00	0.00	0.00	0.47	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	12.22	3.54	0.64	0.32	0.00	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	2.14	0.71	0.71	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.94	0.58	0.58	1.75	0.58	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.65	1.20	0.90	0.90	0.30	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	1.19	1.19	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	1.02	0.00	1.02	0.51	0.00	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.50	2.55	1.53	0.25	0.25	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	1.91	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.08	3.02	0.86	0.86	0.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	10.58	1.91	0.85	1.06	0.21	0.85	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.15	1.74	0.00	1.16	0.29	0.00	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	0.94	0.94	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.00	2.88	1.36	0.34	0.00	0.51	0.00	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	6.95	2.32	0.00	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	13.08	0.64	0.86	0.43	0.00	0.21	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.24	2.41	1.80	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	2.92	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	9.66	3.45	0.69	0.92	0.23	0.69	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	0.00	0.00	2.55	0.00	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.17	2.29	0.76	0.76	0.25	0.25	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.10	2.89	1.03	0.62	0.21	1.03	0.00	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.69	4.59	0.92	0.00	0.00	0.00	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	2.87	1.43	0.00	0.48	0.48	0.00	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.75	3.33	1.55	1.11	0.44	0.44	0.22	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	3.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	3.32	0.00	0.55	0.00	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.24	2.91	0.79	0.26	0.00	0.26	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.72	3.27	0.36	1.45	0.00	0.36	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	21.12	4.79	0.25	1.47	1.60	1.47	0.12	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	10.10	2.40	0.34	0.51	0.68	0.17	0.00	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	9.65	1.89	0.00	1.89	0.63	0.42	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	27.89	5.58	0.70	1.05	0.35	0.35	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	31.06	5.50	0.49	2.91	0.97	0.81	0.16	0.16	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	40.27	4.62	0.15	3.13	1.19	1.94	0.30	0.15	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	39.91	10.67	0.57	5.28	1.49	1.38	0.69	0.11	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	42.97	9.40	0.88	2.76	2.13	1.00	0.63	0.13	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	45.52	9.33	0.57	5.46	0.57	0.91	0.23	0.00	0.23
Basophils, donor1	12241-129G9	26.15	6.28	8.37	1.31	0.26	0.52	0.00	1.05	0.26
Basophils, donor2	12242-129H1	35.00	10.10	7.22	2.89	0.00	1.08	1.08	0.36	0.72
Basophils, donor3	12243-129H2	21.90	4.41	6.17	1.76	0.44	1.03	0.44	0.59	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	23.29	3.02	0.22	1.29	0.65	0.22	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	0.46	0.46	0.00	0.91	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	0.00	1.88	0.00	1.88	1.26	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	13.93	1.46	0.62	0.83	0.83	0.62	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	10.13	2.07	0.23	0.69	0.46	1.15	0.00	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	37.61	5.22	0.36	0.72	0.54	0.90	0.00	0.18	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	14.02	2.58	1.65	2.27	1.03	0.52	0.21	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	17.47	5.59	1.86	1.63	0.93	0.93	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	24.30	7.99	3.84	3.84	0.64	0.32	0.00	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	20.68	20.68	10.34	10.34	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	39.45	10.71	10.71	3.38	0.00	0.56	1.13	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	42.13	8.17	9.65	1.48	0.56	0.56	0.19	0.56	0.74
CD14+ Monocytes, donor3	11381-118B4	41.27	9.66	12.07	0.88	1.54	0.88	0.22	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.08	16.13	1.98	5.94	1.13	0.57	6.51	0.57	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	36.77	10.61	3.03	1.90	0.38	1.14	3.79	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.00	14.14	3.62	3.62	0.66	0.99	5.59	0.33	4.93
CD14+ monocytes - mock treated, donor1	11863-125A9	31.37	6.22	7.95	1.01	0.14	0.72	0.29	1.30	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	23.23	6.03	5.43	0.30	0.00	1.51	0.00	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	34.59	8.53	9.00	2.61	0.24	1.18	0.24	0.71	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	27.96	4.52	5.69	1.00	0.33	0.67	0.33	0.33	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.29	4.69	6.62	1.66	0.00	1.10	0.28	0.83	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	32.97	3.97	7.19	1.49	0.25	1.24	0.00	1.24	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	27.61	4.31	5.48	1.37	0.39	1.76	0.00	0.98	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	19.23	4.63	4.63	1.96	0.71	1.07	0.36	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	28.73	5.22	6.31	0.87	0.00	1.09	0.22	0.65	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	31.61	4.45	4.21	0.70	0.00	0.94	0.00	0.00	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.35	2.11	4.75	1.58	1.58	0.00	0.00	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	32.17	1.11	4.44	0.00	1.11	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	25.29	4.46	7.73	1.93	0.15	0.59	0.59	0.74	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.36	2.79	5.79	0.60	0.20	1.60	1.00	0.20	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	26.86	4.79	5.41	1.87	0.21	1.04	0.00	0.83	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	29.06	3.89	6.41	0.92	0.46	0.69	0.00	0.46	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	27.82	5.66	5.43	2.94	0.23	0.68	0.45	0.90	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.75	2.18	6.55	0.44	0.87	2.18	0.00	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	34.43	5.11	9.15	1.34	0.54	0.27	0.54	0.54	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	26.17	6.28	9.25	1.92	0.35	0.70	0.35	0.87	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	41.24	7.15	11.78	1.26	0.42	1.26	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	35.09	5.51	8.45	0.92	0.55	1.65	0.00	0.92	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	38.40	6.69	5.64	2.47	0.70	0.70	0.35	1.41	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	50.01	7.46	13.60	1.75	0.44	0.88	0.00	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	24.76	4.18	3.49	1.05	0.52	1.22	0.35	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	15.61	7.43	5.20	1.86	0.37	0.74	0.00	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	34.49	6.25	5.82	1.51	0.00	1.29	0.00	0.65	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.98	2.87	5.73	1.23	0.82	0.82	0.00	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	28.74	5.10	9.50	1.39	0.46	1.39	0.23	0.70	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	28.30	6.26	7.19	0.93	0.23	0.46	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	18.31	8.94	1.96	3.05	0.00	1.31	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	20.56	7.39	2.54	1.62	0.69	0.92	0.00	0.23	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	20.80	6.72	3.68	2.82	0.22	0.43	0.00	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	40.64	12.30	4.52	3.89	0.16	1.56	0.00	0.62	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	27.77	9.61	4.02	2.10	0.17	1.40	0.17	0.52	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	65.78	15.61	9.36	5.13	0.22	3.12	0.22	1.34	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	18.63	6.63	2.30	2.30	0.26	0.51	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	21.74	7.90	2.63	2.20	0.66	0.44	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	26.11	9.69	2.32	2.74	0.21	1.05	0.00	0.63	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	10.16	2.03	10.16	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	19.66	12.20	5.42	1.36	0.00	0.00	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	17.61	4.14	2.07	7.25	1.04	1.04	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	22.39	12.26	2.67	3.20	1.07	0.53	0.00	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.40	9.65	1.07	3.75	1.61	0.54	1.07	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	15.44	7.72	0.70	2.11	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	16.47	7.84	0.78	3.92	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	7.91	3.95	1.32	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	36.99	18.90	3.29	2.47	0.82	0.00	0.00	0.82	1.64
CD19+ B Cells, donor2	11624-122B4	43.53	22.49	3.63	5.80	0.00	0.73	2.18	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	37.36	12.62	2.02	4.04	0.50	1.51	1.01	1.01	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	37.98	8.89	0.40	2.02	3.23	0.81	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	16.38	8.39	0.40	2.40	2.80	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	19.08	7.03	6.02	2.01	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	50.56	7.30	7.87	1.12	0.56	0.56	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	15.03	4.88	2.25	1.13	0.38	0.38	0.00	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	17.81	4.74	2.71	1.58	0.23	1.13	0.00	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	92.12	19.64	2.86	9.28	0.00	1.07	0.00	0.36	0.71
CD4+ T Cells, donor2	11306-117C1	64.30	15.31	3.67	1.84	1.22	1.22	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	43.92	14.03	2.13	3.66	0.61	1.22	1.22	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	34.46	14.80	2.81	3.83	1.53	2.30	0.00	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	36.38	10.56	1.35	4.04	0.22	1.35	0.22	0.45	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	47.72	13.80	2.01	2.87	0.57	0.29	0.00	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	39.35	13.27	0.47	3.79	0.95	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	42.14	10.53	0.70	3.51	0.00	1.40	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	9.89	0.00	6.59	0.00	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	25.72	10.41	2.31	5.06	0.72	0.72	0.43	0.43	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	20.50	9.15	1.36	3.05	0.00	0.34	0.34	0.17	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.79	7.58	0.81	5.48	0.32	0.48	0.16	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	29.14	11.66	3.14	4.93	0.45	1.34	0.45	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	39.83	16.42	2.45	4.89	0.35	0.00	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	62.92	21.12	2.20	5.28	1.32	1.32	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	43.85	15.60	0.84	3.37	0.42	0.84	0.00	0.00	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	26.80	7.27	1.87	3.74	0.62	0.21	0.21	0.21	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	30.41	7.68	1.34	3.34	0.67	1.00	0.00	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	60.10	23.93	0.54	6.25	0.00	1.63	0.54	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	51.45	21.97	2.68	1.61	0.00	1.61	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	57.38	12.55	0.00	1.79	0.00	3.59	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	37.46	13.17	3.34	4.64	0.74	0.93	0.19	0.74	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	27.51	11.48	1.30	2.82	0.00	1.52	0.22	0.00	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	40.56	10.51	3.15	3.36	0.84	1.68	0.21	0.21	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	36.91	10.62	1.52	2.53	0.00	1.01	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	37.69	10.83	0.87	3.47	0.00	0.87	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	59.27	11.77	2.61	5.23	0.44	0.87	0.00	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	41.57	16.83	2.47	4.45	0.99	1.48	0.49	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	23.08	3.69	0.92	5.54	0.92	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	6.98	1.40	4.19	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	41.82	17.72	2.77	1.94	0.55	1.38	0.28	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	37.54	19.39	2.70	2.70	0.98	2.45	0.98	0.25	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	40.04	24.64	1.54	10.78	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	39.39	15.04	2.15	3.22	0.36	0.36	0.00	0.00	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	31.85	22.16	1.38	2.77	2.77	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	64.50	21.61	10.80	3.27	0.98	0.33	0.98	1.64	0.65
CD8+ T Cells, donor2	11307-117C2	56.31	9.39	10.14	3.75	0.75	0.75	0.38	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	54.79	18.94	7.83	5.05	1.26	1.26	1.77	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.76	3.67	0.00	2.29	0.69	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.58	3.59	0.72	1.20	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.50	3.83	0.55	0.55	0.00	0.27	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	10.21	2.40	0.90	0.90	0.90	0.60	0.30	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.72	4.32	0.24	0.96	0.24	0.48	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.41	2.05	0.68	1.59	1.82	0.45	0.23	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	20.42	3.26	0.22	1.52	0.43	0.65	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.58	4.47	0.53	1.32	0.00	1.05	0.00	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.48	2.35	0.94	0.47	1.41	0.23	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	24.75	5.13	0.60	2.72	1.81	1.21	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	23.53	5.23	0.87	1.16	1.16	0.29	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.38	3.46	0.80	2.66	1.87	0.53	0.27	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.14	4.38	3.94	1.75	1.75	2.19	0.00	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.60	4.10	3.64	2.73	1.82	4.10	0.91	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.82	5.97	3.73	3.73	0.75	2.98	1.49	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	9.00	2.52	1.08	1.08	1.80	1.44	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.62	2.88	0.00	0.29	1.44	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	6.84	0.71	0.71	0.94	0.71	0.24	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.63	3.17	0.32	0.32	0.63	0.95	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	14.15	2.46	0.31	0.62	0.31	0.31	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	11.22	2.24	0.00	1.28	0.96	0.64	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	21.04	5.35	1.53	2.29	0.00	0.76	0.76	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	15.76	4.73	0.00	0.39	0.39	1.18	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	2.27	0.00	0.76	0.76	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	57.81	7.23	4.82	1.61	4.82	3.21	2.41	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	50.36	11.89	3.50	4.20	2.10	2.80	1.40	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	40.07	7.01	5.01	7.01	1.00	3.01	1.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	34.73	9.14	1.83	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.34	2.47	0.49	1.98	0.00	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	17.36	3.68	0.84	0.84	0.42	0.84	0.11	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	21.84	2.77	1.04	0.35	0.00	1.04	0.00	0.35	0.69
Chondrocyte - de diff, donor2	11338-117F6	6.40	3.55	0.71	2.13	0.71	1.78	0.36	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	21.62	4.66	0.34	1.14	0.34	1.25	0.00	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	9.85	8.06	0.00	0.90	1.79	1.79	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	17.39	4.85	0.81	2.02	0.40	1.21	0.00	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	32.13	7.92	0.57	3.79	0.46	1.61	0.00	0.34	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	27.15	5.99	0.21	3.21	0.64	1.28	0.00	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	26.20	5.49	0.35	1.68	0.80	1.15	0.18	0.09	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	29.07	7.06	3.85	4.40	3.76	1.01	4.49	0.46	0.28
Corneal Epithelial Cells, donor1	11526-119I5	23.06	2.63	0.66	0.66	1.54	2.20	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	25.03	3.41	1.14	0.00	1.14	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	21.98	2.81	0.51	1.02	0.00	1.53	0.26	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	27.90	5.45	0.50	2.31	0.17	0.33	0.33	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.18	5.05	1.58	3.15	0.95	0.95	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	0.00	0.00	3.45	0.00	3.45	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.87	4.32	0.43	1.94	0.76	0.43	0.43	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	41.00	8.88	2.73	1.37	0.00	0.34	0.00	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.81	5.22	1.96	1.31	0.65	1.96	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	42.59	7.26	1.94	0.48	0.00	0.97	0.00	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	7.00	1.33	14.84	0.67	0.50	0.67	0.17	1.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	1.76	10.56	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.64	3.39	24.32	1.41	0.85	0.57	0.00	1.13	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	7.47	1.97	12.98	0.39	0.00	0.39	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.53	0.87	13.96	0.87	0.29	0.29	0.00	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	13.88	1.41	21.65	0.00	0.47	0.71	0.00	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	7.01	1.05	10.87	0.18	0.53	0.53	0.00	0.18	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	16.40	3.55	15.96	1.55	0.44	1.11	0.00	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	18.56	2.13	26.78	2.13	0.30	1.22	0.00	1.83	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	11.84	1.69	41.16	2.26	0.56	1.13	0.00	2.26	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	8.02	0.30	12.78	0.89	0.30	0.89	0.00	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	3.64	1.04	8.85	0.00	0.52	0.52	0.00	0.52	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	6.66	1.28	10.49	0.43	0.28	0.00	0.00	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	13.60	4.40	28.81	0.40	1.60	0.80	0.00	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	9.96	0.52	11.53	0.00	0.00	1.57	0.52	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	14.91	4.22	23.23	1.49	1.86	0.37	0.37	1.86	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.77	3.04	26.07	1.52	2.39	0.87	0.87	0.87	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	12.70	2.93	25.52	0.73	1.83	0.12	0.49	0.85	0.12
Endothelial Cells - Vein, donor1	11267-116G7	5.69	0.00	21.61	0.00	0.00	0.00	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	7.68	2.79	14.67	0.00	0.70	0.00	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.64	0.94	17.11	0.47	0.31	0.47	0.00	0.79	0.31
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	123.77	23.10	49.51	6.60	6.60	1.65	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	96.30	17.83	21.40	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.35	0.98	0.24	0.73	0.73	1.71	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	24.63	3.69	1.64	1.23	1.23	0.41	0.41	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.53	0.77	0.44	0.44	0.11	0.77	0.00	0.11	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.67	3.79	0.11	1.41	0.00	0.76	0.43	0.11	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.28	3.76	0.85	1.58	1.21	0.85	0.73	0.00	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	36.85	6.82	0.96	2.18	0.55	2.18	0.41	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.51	4.96	0.32	1.48	0.74	0.42	0.42	0.21	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	14.49	6.85	1.05	0.79	0.79	1.05	0.53	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.95	4.98	2.99	0.66	0.66	1.00	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	11.34	2.72	0.91	0.91	0.91	1.81	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.13	2.27	3.79	1.52	0.00	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	15.14	2.21	0.32	0.79	0.32	0.79	0.16	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	31.22	9.40	0.91	3.33	0.30	1.52	0.30	0.30	0.61
Fibroblast - Cardiac, donor5	11456-119A7	12.31	2.79	4.82	0.38	0.76	0.51	0.25	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	15.16	3.64	4.24	0.76	1.21	0.76	0.00	0.76	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	18.62	4.15	0.27	0.94	0.80	0.80	0.00	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	16.83	5.61	0.00	1.29	0.00	1.29	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	5.86	0.00	1.46	1.46	0.00	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	14.30	2.54	0.69	1.61	1.38	1.61	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	25.10	4.92	0.00	2.04	0.68	0.51	0.17	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	14.79	4.46	0.23	2.58	0.47	0.94	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	16.51	7.08	6.60	0.94	0.47	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	18.74	3.02	0.12	1.45	0.24	0.73	0.36	0.00	0.36
Fibroblast - Dermal, donor4	11450-119A1	14.02	2.49	0.11	0.57	0.90	0.79	0.00	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	15.00	5.06	0.35	0.70	0.70	0.87	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	19.49	3.41	0.49	0.65	1.95	0.81	0.16	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	28.32	5.00	0.62	1.46	0.42	3.12	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	27.51	6.55	0.79	2.10	0.52	2.62	1.05	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	26.49	4.61	0.26	2.37	1.45	0.79	0.00	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	28.72	6.67	0.00	2.32	0.68	0.87	0.39	0.10	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	3.12	0.00	0.00	0.00	0.00	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	19.56	4.41	0.35	1.76	1.06	1.23	1.23	0.18	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.89	5.30	1.25	1.56	0.94	0.78	0.00	0.00	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	21.23	5.81	0.27	2.16	0.54	0.68	0.41	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	54.34	17.64	1.41	7.06	3.18	0.71	1.41	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	13.89	5.56	0.15	2.05	1.46	0.88	0.29	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.91	5.86	0.41	1.23	0.68	0.82	1.09	0.27	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	17.33	5.16	0.88	1.76	1.32	0.66	0.33	0.11	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.99	6.31	0.44	2.35	1.61	1.03	2.20	0.00	0.88
Fibroblast - Lung, donor1	11270-116H1	1.36	1.36	0.00	0.00	0.00	2.72	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	23.87	10.45	0.00	2.98	1.49	1.49	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	18.15	2.53	0.21	1.06	0.21	0.42	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	19.99	2.50	1.67	0.00	0.83	0.83	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	1.40	0.00	0.00	0.00	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	5.60	2.52	0.00	0.56	0.00	0.56	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	16.64	6.50	0.41	2.44	0.00	2.44	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	24.63	5.04	0.19	1.94	2.72	0.78	0.58	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	34.89	6.22	0.61	2.28	1.82	0.76	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	44.06	8.57	0.61	4.90	1.53	2.14	0.31	0.31	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	12.21	8.78	0.38	0.76	1.14	0.76	0.38	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	11.07	4.05	0.54	1.62	0.54	0.81	0.81	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.74	4.06	0.23	1.74	1.04	1.28	1.97	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.04	3.32	2.54	1.88	0.44	0.77	0.00	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	17.07	6.50	0.00	2.24	1.02	2.24	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	3.34	0.00	2.00	2.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	12.26	3.56	0.00	0.40	0.79	1.98	0.00	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	35.13	7.54	1.79	0.99	0.60	1.39	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.38	7.64	0.89	3.02	0.18	1.95	0.00	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	27.00	5.12	0.39	1.77	0.20	0.59	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	31.29	5.42	1.81	1.20	0.00	0.30	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	34.54	5.61	0.97	0.76	1.08	1.62	0.22	0.11	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	33.41	8.60	0.00	1.27	0.00	2.02	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	23.79	5.58	0.49	3.61	0.66	0.16	0.16	0.00	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	47.52	7.22	1.20	3.81	1.20	0.80	0.20	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	28.93	5.32	0.90	0.90	1.21	0.70	0.10	0.00	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	47.45	12.09	1.21	2.12	0.91	1.51	0.00	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.16	7.79	0.58	3.23	0.41	1.41	0.25	0.00	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	24.79	7.52	0.51	2.05	0.51	0.85	0.51	0.17	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.60	6.24	0.99	0.33	0.66	1.31	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.26	6.60	0.75	0.85	1.49	0.64	0.11	0.00	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	17.37	4.89	0.67	1.52	0.84	0.17	0.00	0.00	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.11	3.45	0.16	0.63	0.63	0.16	0.00	0.31	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	10.46	3.49	2.61	1.74	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	26.18	4.16	1.39	1.56	2.95	2.60	0.35	0.00	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	33.31	2.60	1.82	4.68	2.60	1.04	0.78	0.00	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	35.52	3.58	2.30	2.56	3.32	2.56	0.51	0.51	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	9.95	5.36	0.77	2.30	1.53	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	18.50	3.19	0.00	0.64	1.91	0.00	1.91	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	21.39	4.85	0.57	2.00	7.99	1.71	0.86	0.00	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	45.78	7.45	1.10	2.76	3.03	0.83	10.48	0.00	3.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.28	8.22	0.68	3.42	2.97	0.00	2.97	0.23	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	24.77	5.15	0.00	2.97	5.15	0.59	1.19	0.00	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.14	8.19	0.53	4.49	6.34	0.26	9.52	0.00	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	37.51	6.52	0.33	1.96	1.96	0.98	3.59	0.00	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.04	3.10	0.00	1.77	4.86	0.44	1.77	0.00	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.90	8.34	0.14	1.98	1.41	0.57	0.57	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	45.81	6.77	0.25	1.97	1.11	0.99	0.62	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.38	6.98	0.00	1.07	1.61	0.54	0.27	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	41.01	10.04	0.37	2.11	3.22	1.49	0.12	0.12	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	44.16	6.92	0.42	0.97	4.98	1.25	0.83	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	34.97	7.32	0.41	1.83	1.22	0.81	0.20	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	39.93	6.39	0.23	2.28	2.28	1.37	0.23	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	36.50	6.23	0.62	2.49	3.61	0.87	0.87	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	51.15	8.74	0.44	3.06	3.93	1.09	0.44	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	39.30	8.57	0.30	1.48	0.89	1.18	0.30	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	45.78	6.99	0.48	2.38	3.02	1.27	1.27	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	40.89	7.15	0.67	1.34	3.57	0.45	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.96	7.26	0.40	1.61	2.82	1.41	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	36.81	8.82	0.17	1.70	2.71	0.85	1.19	0.17	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	56.48	9.75	0.98	3.55	2.31	2.48	1.24	0.00	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	72.01	10.30	0.73	3.23	0.73	2.08	1.14	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.38	11.10	0.34	2.56	1.20	2.22	0.17	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	42.71	8.08	0.55	1.66	1.66	1.66	0.33	0.00	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	50.25	8.90	0.58	3.66	1.66	1.66	0.75	0.17	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.66	11.43	1.02	3.47	2.04	2.86	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	37.34	6.81	0.21	2.27	1.44	2.48	0.21	0.00	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	48.42	7.96	0.69	1.38	1.96	1.27	1.15	0.12	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	42.02	9.34	0.50	2.33	1.50	0.67	0.67	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	39.02	7.27	0.66	0.88	1.76	1.10	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	46.49	6.40	0.00	2.09	0.49	0.98	0.61	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	52.03	6.32	0.49	1.30	2.43	1.46	0.00	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	47.79	9.62	0.00	1.28	0.00	1.60	1.28	0.00	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.94	6.44	0.66	1.99	1.23	0.95	0.85	0.19	1.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	33.69	8.70	0.79	1.42	1.74	1.74	0.63	0.00	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	40.75	6.39	0.91	2.13	1.22	1.52	1.22	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	40.56	5.65	0.63	1.88	1.57	1.36	0.94	0.10	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	35.35	6.15	0.66	1.10	1.32	0.22	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	41.80	7.57	0.84	1.68	1.12	0.56	1.40	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	42.68	5.83	1.02	2.69	1.20	2.13	0.93	0.19	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.21	5.88	0.27	1.87	1.60	1.87	0.80	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	37.03	8.42	1.53	1.99	1.38	2.45	0.31	0.15	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.15	4.15	0.78	1.17	1.94	1.17	0.52	0.13	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	28.73	5.69	0.27	2.17	0.54	1.08	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	39.27	7.01	0.37	1.29	1.66	2.77	0.55	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.04	6.14	0.00	1.97	1.32	2.85	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	65.46	13.88	0.00	2.98	0.00	7.93	1.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	36.14	6.07	0.40	1.85	0.53	1.32	0.00	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	30.87	6.66	0.61	2.82	0.20	0.81	0.40	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	92.26	18.55	1.02	4.83	2.03	5.59	1.52	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	48.17	7.56	0.20	1.39	1.79	1.59	0.20	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	38.36	6.47	0.15	1.69	0.77	0.77	1.23	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	45.21	11.87	0.61	2.86	3.48	0.82	0.41	0.00	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.46	2.82	0.00	0.63	1.25	0.31	0.00	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	12.43	3.96	0.28	0.85	1.13	0.00	0.28	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	16.14	2.77	0.00	1.38	1.38	0.92	0.92	0.46	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	19.80	7.42	0.00	0.00	2.47	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	19.73	4.64	0.39	2.32	1.55	1.16	1.55	0.00	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	4.81	0.00	1.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	5.22	0.00	1.74	1.74	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	14.00	4.56	0.00	0.98	4.23	2.28	1.30	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.77	7.00	0.41	2.47	0.41	1.24	0.82	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	13.33	0.00	0.00	0.00	0.00	3.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.06	5.59	0.00	0.56	2.80	0.84	1.40	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.00	3.60	0.98	1.96	1.96	0.98	0.98	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	27.68	3.36	0.84	1.68	2.52	0.84	0.84	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.53	2.54	0.95	1.27	2.86	0.64	0.64	0.00	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.68	6.79	0.34	1.36	3.06	0.34	0.00	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	2.09	2.09	2.09	0.00	0.00	0.00	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	28.06	5.73	0.00	1.15	1.15	0.57	1.15	0.00	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	17.46	1.18	0.59	1.78	0.30	0.89	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	3.39	3.39	0.00	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.54	5.38	0.83	0.41	0.83	1.66	0.83	0.00	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	25.08	4.83	1.38	1.15	2.30	0.92	0.23	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.45	5.77	1.92	1.54	0.77	1.15	1.54	0.00	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	17.28	2.93	0.65	1.63	2.28	1.30	0.98	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	11.37	3.34	0.67	0.67	0.67	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	22.73	4.24	0.77	1.93	3.08	0.00	1.93	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.02	6.16	0.34	2.40	2.74	1.71	1.37	0.00	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	19.88	2.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	28.31	4.72	0.00	1.89	1.89	0.47	0.47	0.00	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	25.35	5.43	0.60	0.60	1.81	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	24.93	5.60	0.51	2.03	2.03	0.51	2.03	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.12	7.58	0.80	0.80	1.99	0.40	0.40	0.00	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.65	2.47	1.48	1.97	2.96	0.49	0.99	0.00	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	27.15	5.90	0.00	0.00	1.18	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	17.50	4.08	0.58	1.17	0.58	0.58	0.00	0.00	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	35.99	8.78	0.88	1.32	3.95	0.44	3.95	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	3.39	0.00	1.70	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	17.31	5.37	1.19	0.60	1.19	0.60	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.90	2.91	0.49	0.97	1.94	0.49	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	2.28	1.14	2.28	0.00	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.55	4.57	0.83	1.66	0.00	0.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	4.50	0.00	2.25	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.64	6.34	0.95	1.59	0.63	0.63	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.44	3.34	0.42	0.84	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	23.21	3.83	0.46	1.16	0.93	0.93	0.23	0.00	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	17.39	2.70	0.17	1.35	2.03	0.84	0.00	0.00	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.70	5.69	0.23	0.91	0.68	0.68	0.00	0.00	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	20.66	3.50	0.66	0.98	1.09	0.55	0.00	0.00	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.70	3.87	0.21	1.72	1.72	0.86	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.93	3.88	0.22	1.08	1.29	0.65	0.00	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	15.44	2.49	0.00	1.00	0.62	0.62	0.12	0.00	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.01	2.40	0.00	1.54	2.40	0.86	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.89	2.88	0.00	1.92	0.96	0.00	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	1.12	13.99	0.56	0.56	1.12	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.95	0.43	3.46	0.00	0.87	0.00	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	18.51	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	8.82	2.82	0.71	0.71	0.00	1.06	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	2.91	0.00	0.00	0.00	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.84	1.57	1.40	1.05	0.35	0.52	0.00	0.00	0.17
Hepatocyte, donor1	11523-119I2	33.90	8.47	2.42	0.00	0.00	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	32.32	6.46	0.00	1.08	0.00	4.31	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	30.06	3.07	4.29	3.68	0.00	0.61	0.61	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	47.65	10.44	0.00	2.61	0.65	0.65	0.00	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	37.93	4.37	0.87	2.62	0.87	0.87	1.05	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	16.05	4.12	0.27	1.78	0.27	0.96	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	1.38	0.00	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	2.50	0.00	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	23.74	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	4.87	0.00	0.00	0.00	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	1.67	0.00	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	0.00	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	14.56	2.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	3.33	0.00	0.00	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	7.56	1.89	0.00	1.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	1.61	0.00	1.61	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	11.41	0.81	0.00	1.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	11.33	3.36	0.00	0.00	0.00	0.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.86	0.80	0.00	0.00	0.80	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	1.85	0.00	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.02	0.47	0.00	1.42	0.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	0.00	0.00	0.00	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	1.08	0.00	1.08	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	5.08	0.00	0.00	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.84	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	1.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.14	3.57	0.71	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	6.48	1.23	0.00	0.62	0.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	3.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	0.70	0.00	2.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	6.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	2.62	0.00	0.00	0.00	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	2.25	0.00	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	5.33	3.20	0.00	2.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	0.00	0.00	1.39	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	2.85	0.00	2.85	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.05	1.84	0.00	2.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	4.23	0.00	0.00	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	67.32	7.26	0.73	4.32	1.96	2.61	0.65	0.16	0.57
Keratinocyte - epidermal, donor2	11349-117G8	19.33	2.93	0.59	0.00	0.59	1.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	36.35	4.54	1.33	2.27	1.61	1.99	0.09	0.00	0.76
Keratinocyte - oral, donor1	11251-116E9	57.89	8.63	1.70	2.16	1.14	2.95	0.34	0.23	1.93
Keratocytes, donor1	11527-119I6	11.00	2.75	0.34	0.00	0.34	2.06	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	0.00	0.00	2.34	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	31.81	5.14	0.00	0.99	0.40	2.37	0.20	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	2.20	4.40	2.20	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	9.71	4.31	1.08	2.16	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	20.88	7.15	0.12	1.61	1.38	1.85	0.12	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	29.87	6.56	0.71	2.93	0.71	2.42	0.10	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	7.23	2.37	13.16	0.59	0.47	0.71	0.24	0.71	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.37	1.12	9.21	0.56	0.56	0.00	0.00	1.12	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.19	0.94	14.80	0.63	0.63	0.47	0.00	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.30	3.76	11.83	0.54	0.54	0.54	0.00	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.93	0.63	10.09	0.32	0.32	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.53	1.73	8.41	0.54	0.54	0.11	0.00	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	4.92	2.05	18.47	0.00	0.41	0.82	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.06	1.01	7.84	0.25	0.00	0.00	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	7.04	1.41	8.59	0.56	0.28	0.28	0.00	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	4.35	2.37	11.07	0.40	0.40	0.00	0.00	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.76	0.78	11.25	0.39	0.58	0.39	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.96	0.56	6.30	0.56	0.19	0.56	0.19	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.23	3.14	9.06	0.00	0.70	0.35	0.00	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.01	1.19	9.06	0.72	0.24	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.81	0.82	8.38	0.27	0.55	0.14	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	3.39	1.54	10.16	0.92	0.62	0.92	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.68	0.94	5.61	0.00	0.31	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.04	2.01	10.98	0.55	0.00	0.18	0.00	0.55	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	1.97	12.84	0.33	0.66	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.27	1.46	8.49	0.29	0.00	0.00	0.00	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.24	1.24	7.72	1.00	0.25	0.25	0.00	0.75	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	1.94	13.09	0.97	0.97	0.48	0.00	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.73	4.04	11.58	0.81	0.00	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4.69	0.91	10.90	0.76	0.15	0.15	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.15	0.00	7.26	0.52	1.04	0.52	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.96	1.47	16.54	0.84	0.21	0.42	0.21	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.17	1.20	9.02	0.30	0.15	0.30	0.00	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	2.06	4.13	9.63	0.00	0.00	0.00	0.00	1.38	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.71	2.45	9.03	0.38	0.19	0.38	0.00	0.94	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.30	1.17	7.63	0.32	0.11	0.21	0.00	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.85	1.45	14.05	0.00	0.00	0.00	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	2.32	7.94	0.99	0.00	0.00	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.96	1.24	9.29	0.50	0.00	0.37	0.00	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.14	4.44	18.51	0.37	0.00	0.00	0.00	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.67	1.24	12.11	0.49	0.00	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.77	1.24	7.70	0.27	0.41	0.14	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.04	1.29	12.54	0.32	0.64	0.00	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	12.48	2.13	15.83	2.13	0.00	0.30	0.00	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.14	2.66	9.94	0.56	0.56	0.00	0.00	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.33	1.42	10.31	0.36	0.36	0.36	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	2.42	4.85	0.48	0.00	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.27	0.78	6.38	0.16	0.00	0.00	0.16	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	3.58	0.36	12.89	0.36	0.00	0.00	0.00	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	8.49	1.31	11.43	0.65	0.00	0.00	0.00	1.63	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.18	0.71	4.71	0.24	0.00	0.24	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.69	3.09	13.74	0.50	0.74	0.62	0.25	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.99	1.28	5.38	0.77	0.00	0.51	0.26	1.02	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	4.77	0.60	8.35	0.90	0.30	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	54.38	2.27	0.00	4.53	0.00	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	49.10	6.90	0.77	0.77	0.77	1.53	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	45.28	5.20	0.74	4.45	0.00	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	45.27	9.31	0.42	4.23	0.85	0.42	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	31.65	4.92	0.70	2.81	0.00	0.00	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	34.56	0.93	0.00	1.87	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.46	5.67	0.52	3.61	0.00	1.03	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	35.68	2.38	1.19	1.19	0.00	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	44.33	7.92	0.00	2.26	0.45	1.13	0.68	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	38.39	5.23	0.58	3.20	0.29	1.74	0.00	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.91	3.15	0.45	2.70	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	54.74	8.54	0.14	3.79	0.68	1.90	0.68	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	49.81	6.68	0.51	1.54	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	39.52	3.53	0.35	2.82	0.00	1.41	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	34.65	5.33	0.67	5.33	0.00	2.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	43.30	4.58	0.51	7.13	0.51	0.00	0.51	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	42.16	5.34	0.00	2.67	0.27	1.07	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	42.13	8.88	0.94	1.89	0.76	1.32	0.57	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	49.09	11.04	1.23	1.84	1.23	1.23	0.61	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	51.37	5.71	0.00	2.45	0.82	0.82	1.63	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	43.11	4.79	0.42	3.33	0.42	1.25	0.62	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	47.64	9.53	0.56	2.80	0.56	1.12	0.28	0.00	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	37.09	9.27	0.00	5.15	0.00	2.06	3.09	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	43.84	4.64	0.29	3.48	0.87	1.16	1.45	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	38.86	7.47	0.00	1.79	0.60	1.20	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	38.73	5.53	0.00	1.66	1.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	46.66	7.78	0.00	1.77	0.35	1.06	1.77	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	44.99	10.33	0.37	0.74	0.00	0.74	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	43.75	9.21	1.15	3.45	1.15	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	42.21	8.44	0.77	3.07	0.38	2.69	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	39.63	3.40	0.00	2.26	0.57	1.13	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	41.84	4.92	1.64	2.46	1.64	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	47.00	6.78	0.45	3.16	0.90	0.45	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	32.32	10.05	0.72	5.03	0.72	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	46.31	5.23	0.00	2.99	1.49	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	53.14	7.43	0.74	1.86	0.00	1.49	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	44.80	7.32	0.86	2.15	0.00	0.86	1.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	45.38	7.71	0.86	5.14	0.00	0.00	0.86	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	46.31	9.00	0.00	3.33	0.33	0.33	0.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	44.04	7.24	0.00	2.41	0.60	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	42.66	8.53	0.00	0.00	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	39.87	7.56	0.34	2.75	0.00	0.69	1.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	49.38	5.90	0.00	2.15	1.07	1.07	1.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	43.77	5.39	0.00	0.67	0.00	1.35	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	45.19	7.41	0.00	2.96	0.37	0.00	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	68.61	8.14	1.16	0.00	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	40.19	10.58	2.12	7.40	0.00	0.00	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	48.42	5.60	0.00	1.60	0.40	0.80	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	42.16	5.81	0.00	5.09	0.00	1.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	48.29	9.20	0.77	2.30	0.77	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	48.34	11.35	0.49	0.99	0.00	1.48	0.99	0.00	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	10.35	0.00	3.76	0.00	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	52.80	5.53	1.01	2.51	0.50	0.00	1.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	45.06	9.91	0.45	6.76	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	5.16	0.00	3.44	0.00	1.72	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	47.65	10.24	0.89	2.67	1.34	1.78	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	48.49	8.99	0.00	3.13	0.00	1.56	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	44.86	5.94	0.00	2.64	0.00	2.64	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	47.74	10.90	0.00	2.59	1.04	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.45	7.88	0.88	5.25	0.88	0.44	1.31	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	50.32	8.39	0.00	4.47	0.56	0.56	0.56	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	38.42	7.95	0.88	2.21	0.00	0.88	1.32	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.80	3.86	0.77	4.63	0.39	1.54	0.39	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	52.15	9.62	0.51	4.05	0.00	1.01	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	44.70	7.21	0.96	0.00	0.00	0.48	0.96	0.48	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	48.50	9.14	0.00	4.37	1.99	1.59	1.59	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	51.04	11.54	0.61	3.65	0.00	0.00	1.22	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	35.97	4.15	0.69	1.38	0.69	0.00	0.00	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	44.08	8.74	0.38	3.80	0.76	0.38	1.90	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.93	8.78	0.00	1.03	0.52	0.52	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	41.72	4.23	0.60	0.00	0.60	2.42	0.60	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	37.39	10.46	0.00	1.90	0.63	0.32	0.32	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	50.64	6.93	0.00	2.67	1.07	0.00	1.60	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	44.25	9.19	0.57	1.15	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	45.25	7.71	0.51	3.09	1.03	0.51	0.51	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	58.00	10.61	0.00	2.12	0.00	2.83	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	57.32	7.38	0.57	0.00	1.13	1.70	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.85	8.32	0.42	3.33	1.25	1.25	0.00	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	43.07	9.40	0.00	2.35	0.78	0.78	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	49.27	7.10	0.84	0.42	0.42	0.42	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	37.17	6.97	0.46	2.79	0.00	2.79	0.93	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	36.80	9.37	0.67	2.68	0.00	0.00	0.67	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	45.44	12.83	0.00	1.07	2.14	1.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	57.79	7.27	0.40	2.42	0.40	1.21	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.97	9.18	0.00	6.42	1.84	0.92	1.84	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	60.46	5.33	0.00	0.89	0.89	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	53.57	6.84	0.57	1.71	0.00	0.57	0.57	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	66.72	6.14	0.00	4.60	0.00	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	56.36	3.28	0.00	1.09	0.55	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	60.58	8.46	0.45	3.12	0.00	0.89	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	59.27	7.54	0.00	3.12	0.26	1.56	0.52	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	68.30	9.95	0.00	1.33	0.66	0.66	0.66	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	58.20	14.55	0.00	0.00	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	38.29	9.80	2.28	2.96	0.68	1.60	0.68	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	17.25	6.06	0.18	3.49	1.47	1.28	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	32.38	5.77	0.92	3.67	0.66	1.05	0.00	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	23.36	3.19	3.19	1.59	2.12	1.06	0.53	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	28.20	4.91	2.06	2.85	3.80	3.96	0.00	0.16	1.27
Mallassez-derived cells, donor3	11930-125I4	41.84	5.42	2.08	2.64	1.81	2.36	0.42	0.42	0.56
Mammary Epithelial Cell, donor1	11273-116H4	32.78	4.28	1.59	1.59	0.80	1.69	0.30	0.30	1.69
Mammary Epithelial Cell, donor2	11350-117G9	37.06	5.50	2.32	1.45	2.03	0.87	0.29	0.00	1.16
Mammary Epithelial Cell, donor3	11422-118F9	14.47	2.49	1.50	1.50	1.25	1.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	25.76	8.81	3.39	2.03	0.00	0.68	2.03	0.00	3.39
Mast cell, donor1	11563-120D6	22.71	6.27	10.06	3.35	0.43	1.95	3.35	1.41	0.43
Mast cell, donor2	11565-120D8	31.80	10.40	9.21	6.24	0.00	0.30	5.35	2.08	1.78
Mast cell, donor3	11566-120D9	25.66	10.36	6.75	4.28	0.68	0.23	7.65	0.45	1.35
Mast cell, donor4	11567-120E1	28.54	13.47	6.21	6.38	1.60	1.06	6.38	1.06	2.48
Mast cell, expanded and stimulated, donor5	11940-126A5	27.61	8.87	4.44	3.22	0.33	0.78	2.55	0.33	1.11
Mast cell, expanded and stimulated, donor8	11942-126A7	26.85	5.84	10.51	2.33	0.58	0.00	3.50	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	21.91	7.34	7.34	2.98	0.23	0.57	4.82	0.69	1.03
Mast cell, expanded, donor8	11941-126A6	23.60	9.87	24.94	4.35	1.51	1.51	5.36	1.84	2.51
Melanocyte - dark, donor1	11502-119F8	9.05	1.09	12.04	0.70	0.50	0.50	0.00	0.80	0.40
Melanocyte - dark, donor2	11582-120F7	11.07	6.92	1.04	0.69	0.35	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	28.76	4.56	0.80	1.88	0.80	0.94	0.36	0.14	0.07
Melanocyte - light, donor1	11274-116H5	22.57	4.94	0.24	1.41	0.47	1.18	0.47	0.24	1.41
Melanocyte - light, donor2	11351-117H1	7.51	0.68	0.00	0.00	1.36	1.36	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	7.81	2.60	0.00	0.87	1.73	1.73	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	17.39	3.33	0.42	0.73	0.62	0.94	0.00	0.00	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	18.29	4.30	0.81	1.88	0.00	0.54	0.27	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	39.64	9.91	0.54	2.41	1.34	1.34	0.00	0.00	2.41
Meningeal Cells, donor1	11493-119E8	18.73	4.96	0.62	1.49	0.37	1.61	0.12	0.00	0.37
Meningeal Cells, donor2	11573-120E7	12.32	1.76	0.44	1.32	0.88	0.44	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	20.95	6.85	0.65	2.85	0.73	0.90	0.16	0.00	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.81	7.70	0.00	1.14	0.57	1.14	0.57	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.36	2.11	0.60	0.70	0.20	0.70	0.30	0.20	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	1.31	0.00	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.07	4.31	0.72	0.72	2.15	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	26.05	4.45	0.42	1.48	0.85	0.64	0.42	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.13	2.51	0.00	1.51	0.50	1.51	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	9.45	2.86	0.44	1.32	0.44	0.66	0.22	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	6.58	2.92	0.00	0.73	0.00	0.73	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.82	1.43	0.20	1.02	0.61	0.82	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.44	4.29	0.14	0.83	0.55	0.42	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.04	3.35	0.00	0.37	0.00	0.37	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.00	6.71	0.26	2.76	0.66	0.79	0.00	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.68	1.78	0.30	0.30	1.19	1.19	0.59	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.76	2.56	0.00	1.28	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	22.68	3.54	2.48	0.35	1.06	1.42	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	24.08	5.32	0.00	0.94	1.25	1.25	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.89	2.90	0.00	1.45	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	25.19	2.39	0.00	3.18	0.80	0.80	0.80	0.00	1.86
Mesothelial Cells, donor2	12156-128G5	26.02	1.50	2.50	1.00	1.00	1.00	0.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	21.61	3.18	0.94	1.81	0.94	1.08	0.29	0.00	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	48.61	16.20	4.05	10.80	0.00	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	27.09	5.91	0.74	2.96	1.72	0.99	0.25	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	34.16	4.12	1.18	3.53	1.18	0.88	0.00	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	20.74	0.00	6.91	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	19.84	6.20	0.62	1.55	0.62	1.24	0.31	0.31	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	22.61	4.77	0.83	2.70	0.21	0.62	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	30.03	7.01	1.25	2.25	0.00	1.75	0.75	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.05	13.50	1.40	2.33	0.93	0.47	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	19.47	0.00	38.93	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.18	5.49	0.61	2.44	0.81	0.41	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.93	7.13	1.58	4.36	0.40	0.00	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	0.88	0.88	2.65	0.88	1.77	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	22.42	3.80	0.00	3.80	0.00	0.00	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	6.58	1.32	1.32	1.32	0.00	1.32	2.63	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	19.31	4.03	0.64	0.64	0.85	0.42	0.00	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	22.10	6.45	1.84	1.84	0.92	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.12	7.15	0.89	1.49	0.89	0.30	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	21.80	16.77	3.35	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	17.81	4.01	0.75	1.51	0.25	1.76	0.25	0.50	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	20.20	4.28	0.71	1.43	0.24	0.00	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.33	4.42	3.32	1.66	1.11	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.10	4.60	0.00	1.61	0.23	0.00	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.77	4.63	1.05	1.68	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.79	5.50	1.22	2.04	0.61	0.61	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.16	5.15	1.29	1.07	0.21	0.64	0.21	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.34	4.67	0.44	1.78	1.11	1.11	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.49	4.82	0.44	1.97	1.10	0.88	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	32.45	3.55	1.01	0.51	0.00	1.01	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	24.85	6.63	1.66	4.97	0.00	1.66	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	25.00	6.25	2.45	1.09	0.54	1.63	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	27.35	5.59	0.88	0.88	0.29	0.88	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	25.08	5.45	1.09	0.00	0.00	3.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	15.38	5.77	1.44	0.96	0.48	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	30.02	6.40	1.20	3.60	0.00	0.40	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	6.86	0.00	1.37	1.37	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.52	2.50	1.00	2.00	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	10.19	2.04	6.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.83	3.94	0.44	1.31	0.00	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	26.49	5.52	1.10	1.10	1.10	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	31.38	7.04	1.92	1.92	0.00	2.56	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.55	3.47	0.74	1.24	0.50	0.50	0.00	0.25	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	21.57	2.09	2.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	13.26	4.42	11.05	2.21	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	16.75	3.08	0.68	1.71	1.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	31.51	5.69	2.19	2.19	1.75	0.44	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	33.38	5.68	1.42	1.78	1.07	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.72	3.93	0.84	1.12	0.28	0.00	0.28	0.00	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	19.95	7.48	1.25	0.83	0.42	1.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	33.22	9.32	2.33	1.17	0.58	2.33	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	23.83	5.43	1.51	1.51	0.30	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.88	2.09	0.00	2.09	0.42	1.67	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	4.62	0.92	1.85	0.00	0.92	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	26.18	7.97	0.57	0.57	0.00	0.57	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.14	6.49	1.38	1.80	0.83	0.83	0.00	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.44	4.15	0.52	1.81	0.78	1.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.74	4.29	1.29	3.00	0.43	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	33.67	6.99	1.27	2.54	0.64	3.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	30.16	3.74	1.07	1.07	0.53	1.60	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.34	4.49	0.60	1.80	1.50	1.20	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.63	3.81	0.71	2.54	0.57	0.99	0.14	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.97	5.41	0.32	0.32	0.64	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	30.07	5.75	1.55	2.21	0.44	1.77	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	35.64	9.86	1.14	1.14	0.38	0.38	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	4.55	0.57	3.13	0.85	0.85	0.00	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	25.56	5.16	0.74	1.47	0.25	0.98	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	24.76	5.21	1.30	3.91	0.00	1.30	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	24.40	5.29	0.00	3.82	0.88	1.18	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	30.56	7.78	1.73	2.59	1.44	0.86	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	37.92	8.66	1.24	7.01	0.00	1.24	0.82	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	29.18	6.85	0.60	3.57	0.89	0.89	0.00	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	3.56	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	26.29	6.24	0.33	0.99	0.33	0.00	0.00	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	4.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.93	6.72	0.79	2.17	0.00	0.20	0.00	0.00	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	1.86	0.93	2.79	0.93	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.52	3.76	0.00	0.75	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	14.38	3.73	0.27	0.27	0.27	0.80	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	15.83	8.26	0.45	2.04	0.11	1.02	0.00	0.00	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	2.95	0.00	0.74	0.00	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	26.02	6.96	1.10	1.10	0.37	1.10	0.00	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	1.56	0.00	0.00	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	5.34	2.67	0.53	0.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	25.25	5.05	1.01	1.01	1.01	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	2.53	0.42	2.53	0.42	0.00	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	8.17	8.17	0.00	2.72	1.36	0.00	0.00	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	1.27	0.64	0.00	0.00	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	4.86	0.81	0.00	0.81	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	4.53	3.02	4.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	5.71	22.84	5.71	0.00	5.71	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	16.31	13.05	0.00	0.00	3.26	0.00	0.00	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	4.75	0.00	0.00	0.00	0.00	4.75	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	12.55	0.00	0.00	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	23.27	6.03	0.43	1.72	1.29	0.86	0.43	0.00	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.38	4.18	0.52	1.05	0.52	1.57	0.00	0.00	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	4.67	0.00	0.00	0.67	0.67	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.02	2.09	0.83	1.25	0.83	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	22.06	2.66	0.95	1.33	1.71	0.57	0.00	0.19	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	23.94	3.19	3.19	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	1.36	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	58.80	3.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.79	1.26	0.00	1.26	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	15.57	1.86	0.23	2.09	0.23	0.23	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.70	3.51	0.54	1.62	0.00	0.81	0.27	0.27	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.39	6.52	0.63	1.26	0.42	1.26	0.63	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.34	3.97	0.00	2.48	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.32	3.79	0.00	0.54	1.35	0.81	0.00	0.00	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.20	1.13	0.45	0.68	0.23	0.23	0.00	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.78	2.45	0.33	0.98	0.16	0.33	0.00	0.00	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.05	4.92	1.28	1.28	0.55	1.09	0.55	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	3.18	1.59	1.59	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	2.40	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	27.24	2.63	0.98	3.28	2.30	1.31	0.66	0.00	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.25	2.28	0.49	0.33	0.33	0.65	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	31.04	7.23	1.59	1.23	1.94	1.76	1.23	0.00	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	1.41	0.00	0.70	0.00	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.79	4.14	0.46	0.00	0.00	0.46	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.93	2.25	0.00	0.64	0.00	0.64	0.00	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	28.63	2.76	1.03	1.38	1.72	1.72	0.00	0.00	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	111.25	7.59	5.06	5.06	7.59	5.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.62	7.35	1.11	0.45	1.34	1.78	0.22	0.00	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.31	1.27	0.42	1.69	0.00	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.75	4.03	0.24	1.19	0.95	0.24	0.00	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	12.45	3.43	0.43	0.43	0.00	0.00	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	27.08	0.00	9.03	9.03	9.03	9.03	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.66	7.00	0.33	1.00	0.00	1.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.49	8.57	0.00	3.61	1.80	2.71	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.92	0.79	0.00	1.19	0.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	3.71	0.00	0.93	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	37.08	5.30	0.00	1.89	1.14	0.38	0.00	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.99	3.26	0.65	2.28	0.33	0.98	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.05	5.23	0.87	1.31	0.44	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.97	3.62	1.36	0.90	1.36	1.36	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	4.41	1.76	1.76	0.00	0.00	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.97	1.99	0.66	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	18.85	1.98	0.50	2.98	0.50	0.99	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.31	1.53	0.38	1.15	0.00	0.38	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	31.45	6.65	0.91	0.91	1.21	1.21	0.00	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	24.09	5.30	0.88	2.21	1.55	2.43	0.44	0.00	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	15.59	3.39	0.00	0.00	0.00	0.68	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	112.41	15.33	0.00	0.00	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	19.51	1.83	0.00	2.44	0.00	0.00	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.68	4.41	0.31	0.31	0.00	0.63	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.90	2.72	1.21	0.00	0.30	0.30	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	3.16	0.00	0.79	0.00	0.00	0.79	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	51.01	2.27	0.00	3.40	2.27	0.00	0.00	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	13.67	3.35	0.37	1.61	0.99	0.99	0.37	0.00	0.25
Myoblast, donor2	11322-117D8	14.38	3.26	0.58	2.11	0.77	1.34	0.00	0.19	0.19
Myoblast, donor3	11398-118D3	17.99	4.88	0.67	2.35	0.67	1.01	0.84	0.00	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	12.84	2.77	1.46	0.44	0.58	0.58	0.15	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	56.28	17.22	18.76	5.54	2.77	0.31	1.85	0.62	2.77
Natural Killer Cells, donor2	11311-117C6	59.41	12.67	10.86	6.03	0.90	0.90	2.11	0.90	0.90
Natural Killer Cells, donor3	11387-118C1	53.56	14.36	15.46	5.34	1.84	1.29	1.84	0.18	0.55
Neural stem cells, donor1	11275-116H6	78.76	14.52	1.45	5.44	0.73	2.90	5.44	0.00	3.27
Neural stem cells, donor2	11352-117H2	102.06	25.03	1.93	3.85	1.93	9.63	3.85	0.00	3.85
Neurons, donor1	11494-119E9	36.41	5.69	1.14	3.41	2.28	2.28	2.28	0.00	1.14
Neurons, donor2	11574-120E8	44.69	11.23	0.66	4.18	1.10	4.18	0.88	0.44	0.22
Neurons, donor3	11655-122E8	28.78	2.47	1.64	0.82	0.00	2.47	0.82	0.00	2.47
Neutrophils, donor1	11233-116C9	81.66	25.06	10.21	7.42	1.86	1.86	1.86	0.00	8.35
Neutrophils, donor2	11314-117C9	92.76	11.60	11.60	5.80	2.90	0.00	0.00	0.00	8.70
Neutrophils, donor3	11390-118C4	197.30	39.70	26.27	10.38	4.28	6.11	3.05	1.22	12.83
Nucleus Pulposus Cell, donor1	11252-116F1	18.52	6.17	0.12	2.49	0.59	1.19	0.00	0.12	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	6.19	2.93	0.33	0.98	0.00	0.33	0.00	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	10.63	3.41	0.20	2.01	0.60	0.20	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	13.21	3.03	0.28	1.10	0.41	0.41	0.14	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	18.24	3.91	0.29	2.03	0.00	1.16	0.14	0.00	0.29
Olfactory epithelial cells, donor3	11935-125I9	15.78	3.75	0.45	0.91	0.45	0.68	0.00	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	28.44	8.47	0.29	1.95	0.58	1.17	0.00	0.00	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	31.29	4.21	1.20	1.20	1.20	1.20	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	18.50	3.62	0.43	0.85	1.06	0.85	0.64	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	8.00	2.29	0.00	2.29	0.00	2.29	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.66	3.10	0.00	1.24	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.67	2.15	0.00	0.78	0.20	0.59	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	24.58	7.73	0.00	1.40	3.51	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	19.37	4.62	0.18	1.78	0.89	0.18	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	23.00	5.81	0.42	1.68	0.59	1.10	1.26	0.00	1.10
Pericytes, donor1	11491-119E6	11.02	1.89	0.00	0.33	0.22	0.45	0.11	0.00	0.11
Pericytes, donor2	11571-120E5	5.89	1.36	0.00	0.23	0.00	0.45	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	16.28	1.63	0.00	0.20	1.02	0.81	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	21.70	4.97	0.23	1.70	0.90	1.13	0.00	0.00	0.11
Perineurial Cells, donor2	11579-120F4	14.45	4.69	1.75	1.29	0.55	1.29	0.00	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	85.74	18.17	9.88	3.82	0.96	1.59	0.96	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	29.87	14.45	5.88	3.18	0.24	0.73	0.49	0.73	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	55.91	16.44	5.82	5.18	1.04	1.29	0.39	0.52	0.52
Placental Epithelial Cells, donor1	11278-116H9	8.61	1.67	0.96	0.72	0.00	0.72	0.48	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	4.44	6.65	0.00	2.22	0.00	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	10.99	4.52	0.00	0.79	0.20	1.18	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.99	3.16	0.63	1.90	0.32	0.00	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	11.26	5.82	0.38	2.06	0.94	0.38	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	24.67	5.87	0.65	2.87	0.52	1.17	0.13	0.13	0.39
Preadipocyte - breast, donor2	11328-117E5	20.49	4.28	0.23	2.48	0.23	0.90	0.00	0.23	0.68
Preadipocyte - omental, donor1	11468-119C1	30.05	6.71	0.64	1.39	0.85	1.70	0.32	0.11	1.07
Preadipocyte - omental, donor2	11329-117E6	24.88	5.67	0.00	2.18	0.44	1.31	0.44	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	16.47	4.30	1.15	2.58	1.00	2.01	0.29	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	11.81	1.97	0.00	1.97	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	17.51	3.99	0.00	1.23	0.61	0.31	0.31	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	22.84	3.36	0.00	0.89	0.00	0.53	0.00	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	13.96	4.26	0.34	1.02	0.00	0.34	0.00	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	22.36	6.43	0.47	2.51	0.28	0.75	0.56	0.09	0.47
Preadipocyte - visceral, donor2	11357-117H7	16.11	4.14	0.00	0.46	0.46	0.00	1.38	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	15.46	3.97	0.63	0.73	0.21	0.52	0.21	0.00	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	32.28	4.07	0.30	0.60	2.26	1.81	2.56	0.15	1.06
Prostate Epithelial Cells, donor2	11331-117E8	27.08	3.66	1.76	1.62	0.81	1.62	1.49	0.14	1.22
Prostate Epithelial Cells, donor3	11404-118D9	33.93	4.10	0.43	1.71	1.65	1.90	0.67	0.00	0.80
Prostate Stromal Cells, donor1	11254-116F3	15.38	3.99	0.00	1.71	0.57	0.91	0.68	0.11	0.00
Prostate Stromal Cells, donor2	11332-117E9	16.32	3.23	0.36	1.43	0.72	0.36	0.18	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	11.78	3.02	0.21	1.04	1.04	0.63	0.83	0.00	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.39	4.74	0.00	1.82	1.46	0.00	0.36	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	36.11	5.48	0.35	2.29	1.80	1.52	0.07	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	11.67	1.01	0.51	0.51	0.51	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	2.85	0.00	0.71	0.00	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	29.01	7.20	0.21	2.12	1.06	1.38	0.21	0.21	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	0.00	15.66	0.68	2.04	0.00	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.09	1.08	10.92	0.40	0.67	0.00	0.00	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.20	3.77	8.44	1.55	1.11	0.44	0.00	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.32	0.67	11.31	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.26	3.52	0.22	0.00	0.88	0.88	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	6.27	3.13	0.63	1.25	0.63	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	1.94	0.00	0.55	0.00	0.83	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	18.25	3.22	0.27	2.68	2.42	1.07	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.39	1.27	0.00	1.69	0.84	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.49	2.51	0.00	0.77	0.96	0.77	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	17.89	2.85	0.26	1.30	0.78	0.26	0.26	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.21	3.41	0.00	0.28	0.57	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	1.03	0.00	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	25.09	6.02	0.00	1.25	0.00	1.51	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	34.88	9.35	6.28	2.81	0.67	1.07	1.34	0.53	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	4.47	0.00	0.89	0.00	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	20.36	5.50	0.55	1.65	0.55	1.10	0.00	0.00	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	36.54	11.02	0.58	1.16	1.74	1.16	0.58	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	55.26	12.22	0.78	2.86	2.08	2.73	0.00	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	41.01	7.75	0.20	2.98	1.19	1.29	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	51.42	10.26	0.33	3.35	1.90	2.79	0.11	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	43.17	8.93	0.25	2.23	1.86	1.61	0.25	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	37.76	7.34	0.12	1.63	1.40	1.40	0.23	0.12	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	51.31	8.32	0.00	3.24	2.08	1.16	0.23	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	32.86	7.80	0.55	1.51	2.33	1.64	0.27	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	39.94	8.32	0.30	1.66	1.21	1.82	0.30	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	54.47	9.68	0.00	3.94	2.51	2.69	0.00	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	32.42	9.04	0.29	1.00	1.43	1.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	38.53	6.87	0.64	2.36	1.18	1.07	0.21	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	37.84	7.97	0.22	2.43	2.43	1.33	0.00	0.00	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	42.44	9.94	0.57	2.49	1.53	1.72	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	44.07	9.78	0.00	3.17	1.21	1.40	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	59.00	16.16	0.38	4.89	2.25	1.88	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	48.57	9.29	1.33	1.46	1.59	1.99	0.27	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	47.11	9.05	0.19	3.21	1.65	1.65	0.19	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	39.15	10.12	0.19	2.67	2.67	1.53	0.19	0.38	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.14	9.82	1.07	1.39	1.92	2.03	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	40.92	5.89	0.00	2.52	1.40	1.68	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	51.44	8.20	0.00	3.59	1.03	1.71	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	43.21	10.39	0.36	1.28	1.82	2.73	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	40.22	9.32	0.25	2.45	1.35	0.98	0.00	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	41.50	8.33	0.54	2.69	1.88	1.75	0.13	0.13	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	32.08	9.43	0.71	1.18	1.42	0.71	0.00	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	38.10	7.94	0.00	2.18	0.99	1.39	0.20	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	36.71	7.02	0.94	2.81	2.57	1.87	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.50	6.43	0.41	1.45	1.45	0.62	0.21	0.00	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	55.52	9.29	0.44	3.98	0.66	1.77	0.44	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	43.03	7.73	0.63	1.88	1.46	1.46	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	37.68	9.29	0.67	1.88	1.75	2.02	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	48.02	9.54	1.70	2.04	1.70	2.90	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	51.48	9.64	0.96	3.28	1.74	2.12	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	31.81	9.28	0.52	2.24	0.86	1.55	0.00	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	50.34	10.84	0.55	2.74	0.41	1.10	0.27	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	45.64	11.00	0.82	3.78	1.81	2.13	0.33	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	38.18	10.40	0.00	1.53	1.70	1.70	0.00	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	45.13	8.14	0.30	2.96	1.63	1.63	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	55.71	12.53	0.53	3.20	2.13	1.87	0.53	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	48.95	9.13	0.69	2.90	2.35	1.66	0.14	0.14	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	36.91	9.05	0.00	2.62	3.57	0.48	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	67.11	13.10	0.20	6.05	2.42	1.41	0.60	0.00	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	32.87	8.57	0.19	1.04	2.07	2.07	0.09	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	35.98	9.08	0.35	2.79	1.40	1.40	0.70	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	32.34	5.44	0.00	4.53	0.00	1.51	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	33.29	8.93	0.98	1.35	0.98	1.22	0.24	0.00	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	90.53	17.61	0.87	8.15	2.04	5.24	2.04	0.44	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	34.68	5.48	0.00	2.43	0.61	0.61	3.65	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	26.22	6.33	0.00	1.21	0.90	1.51	0.60	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	29.18	5.88	0.90	1.58	0.45	1.13	1.58	0.00	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	35.94	6.89	0.00	3.00	1.80	2.40	1.80	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	33.42	5.90	0.71	1.06	1.77	1.65	1.18	0.12	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	26.25	6.40	0.21	2.13	2.13	0.21	2.13	0.00	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	35.46	9.01	0.60	4.21	2.40	0.60	5.41	0.00	0.60
Schwann Cells, donor1	11498-119F4	9.03	1.32	0.00	0.19	0.75	0.56	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	9.42	3.72	0.22	1.10	0.22	0.88	0.00	0.00	0.22
Sebocyte, donor1	11220-116B5	48.75	3.29	1.64	2.74	1.64	4.38	0.55	0.00	1.10
Sebocyte, donor2	11301-117B5	34.47	3.68	1.84	2.30	0.92	3.22	0.46	1.38	0.00
Sebocyte, donor3	11378-118B1	20.20	2.68	0.21	0.82	1.24	1.44	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	19.88	4.97	0.00	3.31	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	5.65	0.00	0.00	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.38	7.04	0.26	2.73	0.35	1.06	0.18	0.00	0.70
Skeletal Muscle Cells, donor2	11358-117H8	7.95	1.45	0.00	0.00	1.45	0.72	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	8.36	3.34	0.00	0.00	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	13.67	4.56	0.79	0.63	0.47	0.94	0.00	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	13.23	4.91	0.00	0.45	0.74	0.30	0.00	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	12.31	4.00	0.15	0.92	1.23	0.62	0.00	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.12	7.81	0.00	2.52	1.39	0.50	1.01	0.00	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.54	5.42	0.14	0.71	0.29	0.86	0.14	0.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	22.42	5.85	0.60	1.59	0.69	1.09	0.00	0.00	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	37.16	8.34	0.51	3.79	0.59	0.93	0.34	0.00	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	0.72	0.00	0.72	0.72	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.71	2.06	0.28	0.41	0.28	0.69	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	5.37	5.37	5.37	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.88	4.04	2.59	0.72	1.15	1.44	0.58	0.29	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.07	25.35	13.90	6.54	5.73	9.00	1.64	2.45	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	20.77	3.89	2.34	0.91	0.39	1.17	0.00	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	40.17	4.03	2.22	2.09	1.53	2.22	2.78	0.14	1.81
Small Airway Epithelial Cells, donor2	11334-117F2	35.02	2.53	3.24	1.69	1.55	2.25	0.98	0.14	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	111.22	17.76	13.32	7.40	1.90	5.92	0.42	1.27	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	34.85	4.05	1.57	1.57	1.27	3.22	2.02	0.30	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.95	5.25	0.00	1.23	1.23	1.23	0.00	0.00	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.01	5.34	0.67	1.11	0.44	0.22	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.34	3.53	0.59	1.18	0.59	1.18	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	9.06	1.55	1.77	1.10	0.66	0.66	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	1.97	0.79	1.58	0.79	0.39	0.39	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.91	5.41	0.77	0.77	0.00	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	5.00	0.00	2.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	14.64	1.86	1.33	1.20	0.67	0.67	0.13	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.29	1.77	1.33	1.33	0.66	0.44	0.22	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	17.28	3.33	1.92	0.90	1.15	0.77	1.02	0.13	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	17.91	3.26	0.00	3.58	0.98	1.63	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	24.22	4.43	0.30	2.36	0.00	1.18	0.89	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.23	3.99	1.14	1.00	0.43	1.42	0.57	0.00	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.32	2.28	0.16	0.49	0.33	0.65	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	34.40	4.57	0.61	2.13	0.91	0.91	0.61	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	12.38	3.28	0.51	0.76	0.25	1.01	0.00	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.68	1.91	0.95	0.48	0.95	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	27.87	5.60	0.15	2.36	0.29	1.03	0.15	0.00	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	28.84	3.23	0.65	0.86	0.65	1.08	0.43	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	25.92	5.14	0.21	1.78	0.63	1.15	0.31	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.42	1.24	0.77	0.77	1.24	0.62	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	2.16	2.16	0.00	0.00	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.07	1.79	0.00	0.90	0.60	2.39	0.00	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.15	2.73	0.00	0.34	1.02	0.00	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	22.93	6.20	0.31	1.88	0.24	1.33	0.31	0.00	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	23.45	4.83	0.50	2.72	0.50	0.81	2.52	0.00	2.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.48	3.87	1.37	0.91	0.23	1.37	0.00	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.89	1.21	1.21	0.60	0.60	0.60	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	24.37	3.97	0.53	1.32	1.59	1.32	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	20.64	3.60	0.40	2.13	0.80	1.20	0.00	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.53	4.76	0.50	2.38	0.25	1.50	0.13	0.00	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	9.13	5.07	1.01	1.52	0.51	0.76	0.25	0.00	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.93	5.58	1.06	1.06	1.36	1.81	0.00	0.15	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.00	0.75	0.00	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	2.58	5.17	0.00	1.29	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.49	3.72	1.40	2.79	0.47	1.40	0.47	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.66	2.02	3.53	0.00	0.00	0.00	1.01	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.28	1.25	1.57	0.63	0.31	1.25	0.63	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.54	1.77	0.00	1.18	0.29	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.25	4.42	0.08	1.83	0.83	1.00	0.17	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.15	6.07	0.47	1.40	0.93	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.65	1.58	0.86	0.86	0.29	0.29	0.43	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.79	2.55	1.27	1.02	0.00	0.51	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.09	0.75	0.75	0.94	0.00	0.38	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.84	5.03	0.00	1.82	0.42	0.70	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	22.87	5.28	0.08	1.51	0.92	1.34	0.00	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	2.86	0.48	0.00	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.70	1.47	0.49	0.73	0.24	0.98	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.70	4.20	0.88	0.66	0.22	1.10	1.10	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.21	2.05	0.29	0.88	0.29	0.59	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.21	3.89	0.39	0.58	1.17	1.36	0.19	0.00	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.64	1.85	0.26	1.85	0.00	1.32	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.02	2.98	0.00	0.74	0.37	0.00	0.37	0.00	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	19.76	4.67	0.00	3.23	0.36	0.72	0.72	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	16.75	1.99	0.57	0.57	0.28	1.42	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.09	2.76	0.39	0.79	0.79	0.00	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	11.94	5.84	0.25	1.02	0.51	0.25	1.02	0.25	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	5.59	5.19	0.80	0.80	1.20	0.80	1.20	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	2.51	0.42	0.84	0.00	0.84	0.00	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	19.25	2.75	0.00	0.92	0.92	0.46	0.46	0.00	0.46
Synoviocyte, donor1	11291-117A4	19.36	5.22	0.34	3.03	0.50	1.85	0.50	0.00	0.84
Synoviocyte, donor2	11368-117I9	9.72	3.69	0.67	1.01	0.17	0.17	0.00	0.00	0.17
Synoviocyte, donor3	11440-118H9	16.76	3.35	0.00	1.12	0.00	0.45	0.00	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	10.72	1.43	0.36	1.79	0.36	1.07	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.95	2.08	0.00	0.00	0.00	0.69	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	18.21	2.37	0.79	1.58	1.43	1.22	0.36	0.00	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	10.05	1.55	1.16	0.39	0.39	1.55	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	16.61	1.15	1.72	0.57	0.57	1.15	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	32.72	6.89	5.91	2.46	0.25	1.35	2.21	0.37	0.49
Urethra, donor2	10319-105A4	7.19	3.60	7.19	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	18.33	1.33	0.00	1.33	0.53	1.59	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	16.82	1.60	0.00	1.20	0.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	14.67	2.29	0.46	0.92	0.69	1.15	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	50.15	4.68	0.67	1.56	0.67	1.11	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	48.05	25.80	13.35	4.45	1.78	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	57.18	35.74	7.15	7.15	1.43	4.29	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	37.65	20.54	3.42	2.74	1.37	2.74	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	39.25	17.22	3.44	4.82	1.03	1.72	0.00	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.25	14.53	5.81	6.39	1.16	1.74	0.58	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	65.60	23.95	8.33	4.16	1.04	4.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	50.48	19.27	2.75	1.84	5.51	0.92	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	46.56	17.35	0.91	2.74	1.83	1.83	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	17.89	3.70	0.37	1.73	0.99	1.48	0.37	0.12	0.12
Wilms' tumor cell line:HFWT	10597-108E3	19.36	3.52	0.00	2.64	0.00	6.16	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	26.54	2.51	1.68	3.91	1.12	0.00	0.00	0.28	0.00
achilles tendon, donor2	10292-104G4	8.27	4.13	2.07	0.00	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	12.49	1.78	3.06	1.53	1.78	0.51	0.76	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.84	2.55	0.46	1.39	0.00	0.23	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	40.48	8.67	0.83	2.73	0.95	0.71	0.59	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	31.29	5.17	1.36	2.99	1.09	0.54	0.27	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	5.90	3.37	2.81	0.28	0.56	0.28	0.00	0.00	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	12.90	6.13	5.71	2.33	1.06	0.63	0.21	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	10.62	4.90	6.26	1.63	1.36	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	8.81	5.29	2.20	0.88	0.44	0.44	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	15.11	6.94	4.90	2.04	0.00	0.00	0.00	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	14.37	6.21	1.94	1.55	0.00	0.39	0.00	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	8.65	2.02	0.74	0.74	0.00	0.74	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	11.70	11.70	3.90	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	16.27	5.11	3.49	2.09	0.70	0.93	0.00	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	22.52	5.18	0.52	2.07	0.78	0.00	0.00	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.67	6.14	0.29	2.63	0.88	0.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	9.76	3.72	3.25	3.72	0.93	0.00	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.86	4.52	5.35	2.06	0.41	0.41	0.82	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.37	1.84	1.53	0.92	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	18.78	4.69	0.43	1.28	0.00	1.28	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	16.98	3.94	1.21	2.73	0.30	1.21	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	19.50	6.98	2.41	3.85	0.00	0.72	0.00	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	23.39	8.69	1.56	1.11	1.11	0.45	0.00	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	17.34	4.34	0.33	1.33	1.67	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	14.87	5.57	3.72	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	8.29	3.39	3.77	1.51	0.75	0.75	0.00	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	10.03	1.74	13.08	0.44	3.05	0.00	0.00	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	0.00	20.62	0.00	0.00	3.75	0.00	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	19.08	10.13	0.71	3.53	0.00	1.18	0.24	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	25.75	9.77	10.24	2.17	0.47	0.47	1.40	0.47	0.47
adipose, donor1	10184-103D4	38.70	3.52	1.76	0.59	9.38	1.17	18.77	0.00	6.45
adipose, donor2	10185-103D5	23.11	7.30	0.00	2.84	1.62	0.00	4.06	0.00	1.62
adipose, donor3	10186-103D6	29.95	5.72	1.36	3.54	2.72	1.36	3.81	0.27	2.45
adipose, donor4	10187-103D7	26.87	4.33	0.87	4.33	10.40	0.87	2.60	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	15.31	4.26	1.74	1.74	1.42	0.47	0.16	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	32.74	3.64	0.00	3.64	3.64	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	2.93	1.33	0.40	0.13	0.13	0.00	0.40	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.36	6.07	0.36	1.43	0.36	1.07	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	20.40	5.56	1.85	3.48	0.23	0.23	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	32.46	7.10	0.34	1.69	1.35	1.35	3.04	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	29.46	7.95	0.29	1.18	0.00	0.59	0.59	0.00	1.18
amygdala - adult, donor10196	10167-103B5	47.43	13.04	2.37	3.56	9.49	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	50.49	13.18	1.42	4.06	3.24	0.81	0.41	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	28.73	7.42	1.29	3.87	2.26	0.97	0.97	0.00	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	31.07	7.00	1.66	2.55	0.89	1.15	1.66	0.00	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	15.66	3.31	0.22	1.10	1.76	0.66	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	44.43	9.02	0.67	1.34	1.34	0.33	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	17.06	4.12	2.16	3.14	0.78	0.00	0.59	0.00	0.20
appendix, adult	10189-103D9	24.84	9.31	6.99	0.78	0.39	1.55	6.21	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	15.13	2.75	0.34	1.03	1.72	0.34	1.03	0.00	0.00
artery, adult	10190-103E1	23.10	2.72	6.79	2.72	0.00	1.36	1.36	0.00	2.72
astrocytoma cell line:TM-31	10425-106D2	9.71	1.16	0.43	0.58	0.00	0.14	0.00	0.00	0.00
b cell line:RPMI1788	10427-106D4	38.36	8.03	1.64	4.46	1.04	0.89	1.19	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	19.70	3.88	0.55	1.66	0.55	1.66	0.00	0.00	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	24.11	3.77	1.49	2.08	1.39	1.39	0.20	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	30.96	4.18	0.17	2.01	1.84	0.67	0.84	0.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	5.59	2.80	0.56	2.24	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	25.64	8.37	2.39	2.50	0.54	0.76	1.30	0.00	0.33
blood, adult, pool1	10053-101G8	17.72	2.21	0.00	2.21	0.00	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	9.42	2.57	0.00	1.71	0.00	0.00	0.86	0.00	1.71
bone marrow, adult	10192-103E3	24.97	10.12	2.70	1.35	0.00	1.35	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	33.83	10.25	2.05	4.10	7.18	0.00	2.05	0.00	1.03
brain, adult, pool1	10012-101C3	48.77	15.14	0.78	5.79	5.90	2.12	2.23	0.11	0.67
brain, fetal, pool1	10085-102B4	45.41	5.34	0.00	5.34	2.67	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	62.44	6.28	0.66	2.64	1.65	1.65	0.66	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	102.48	16.60	1.00	6.74	1.62	1.37	0.75	0.12	0.37
breast, adult, donor1	10080-102A8	14.52	5.05	4.42	1.89	0.63	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.13	3.30	0.64	2.03	0.13	1.14	0.13	0.25	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.36	4.95	1.55	1.24	1.24	1.55	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	8.75	2.53	0.23	1.15	0.00	0.23	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.04	4.36	0.24	1.69	0.24	0.48	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	7.52	1.88	0.47	0.94	0.47	0.00	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	36.53	2.52	0.88	1.53	0.22	2.73	0.33	0.55	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	12.99	0.95	0.32	0.95	1.27	0.63	0.95	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	25.02	5.86	0.80	1.60	1.33	0.80	1.60	0.00	0.80
caudate nucleus - adult, donor10196	10177-103C6	40.30	11.51	1.15	1.15	11.51	1.15	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	39.99	12.38	1.67	3.01	3.51	1.34	0.17	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	22.92	15.28	0.00	1.53	8.41	1.53	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	41.38	9.16	0.00	3.30	2.20	1.83	1.10	0.00	1.46
cerebellum - adult, donor10196	10173-103C2	75.75	49.53	0.00	2.91	0.00	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	122.77	33.95	3.84	11.74	2.14	5.55	1.07	0.21	0.85
cerebellum, adult, pool1	10083-102B2	39.67	9.31	1.72	2.07	0.00	1.38	1.03	0.00	1.03
cerebellum, newborn, donor10223	10357-105E6	80.54	28.23	0.83	4.15	4.15	2.49	8.30	0.00	9.13
cerebral meninges, adult	10188-103D8	38.58	9.83	1.26	4.54	6.30	2.02	1.01	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	12.43	0.73	2.19	0.00	0.73	0.00	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	41.27	6.76	0.14	2.73	1.01	2.88	1.44	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	54.69	3.98	4.31	1.66	0.83	3.65	1.82	0.66	1.82
cervix, adult, pool1	10013-101C4	31.60	14.38	5.98	4.72	0.94	1.05	1.99	0.63	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	27.59	4.46	1.67	1.39	0.98	1.25	0.42	0.00	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	3.92	2.61	0.00	1.31	0.00	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	37.41	4.85	0.87	2.49	3.98	1.12	6.59	0.12	1.62
choriocarcinoma cell line:SCH	10785-110H2	10.60	2.46	0.12	0.49	4.44	0.37	0.62	0.00	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	31.31	1.90	0.95	1.42	7.83	1.19	2.61	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	18.52	4.84	1.14	2.56	0.85	1.99	0.28	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	26.35	4.57	0.70	2.49	1.39	2.98	2.59	0.00	0.99
chorionic membrane cells, donor3	12240-129G8	26.92	6.59	1.10	1.10	0.55	0.00	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	15.15	4.04	1.01	3.03	0.00	1.01	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	7.30	2.88	4.61	0.38	0.00	0.00	0.00	0.77	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.12	3.59	2.32	0.84	0.42	0.21	0.00	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	14.12	5.65	0.00	0.77	0.51	0.00	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	17.66	3.87	0.00	1.21	0.48	0.97	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.56	5.09	0.00	1.83	0.20	0.61	0.20	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	20.91	4.12	0.00	2.94	0.59	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	17.98	6.26	3.91	0.78	0.52	1.04	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	10.74	5.03	0.46	3.20	0.23	0.69	0.46	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	22.38	5.21	0.87	1.04	0.87	0.35	0.00	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	16.47	3.29	1.10	0.55	0.37	0.55	0.73	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	41.81	11.02	1.14	2.28	2.28	0.38	0.38	0.00	0.38
colon, adult, donor1	10082-102B1	21.42	3.57	0.00	4.76	0.00	0.00	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	33.49	9.87	3.64	3.88	0.71	0.47	5.29	0.24	0.82
colon, fetal, donor1	10070-101I7	25.34	4.94	1.85	3.09	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	206.26	41.25	45.84	18.33	9.17	13.75	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.47	2.12	3.40	2.55	0.42	0.42	2.12	0.00	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	21.73	6.19	1.06	2.57	0.91	0.91	7.70	0.30	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	23.13	7.19	1.55	2.82	0.99	0.85	0.28	0.28	0.42
corpus callosum, adult, pool1	10042-101F6	46.10	12.05	2.10	5.09	0.33	1.99	1.88	0.11	0.33
cruciate ligament, donor2	10295-104G7	8.92	5.67	7.29	0.81	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	18.46	8.03	8.03	2.41	0.00	0.80	0.00	0.00	0.80
diencephalon, adult	10193-103E4	21.60	7.92	1.20	3.84	1.92	0.48	0.00	0.48	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	14.01	2.53	0.46	0.23	1.15	0.23	0.46	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	30.77	6.67	2.56	2.56	1.54	2.82	1.03	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.52	1.44	0.00	0.96	0.72	0.00	0.96	0.00	0.72
ductus deferens, adult	10196-103E7	15.45	6.98	0.50	2.99	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	14.40	4.32	2.88	0.00	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.81	20.60	2.21	4.41	0.74	2.21	2.21	0.00	0.74
dura mater, adult, donor1	10041-101F5	24.86	8.59	6.03	2.89	0.83	0.25	0.99	0.33	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.43	0.67	1.11	0.44	2.89	0.89	3.11	0.22	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	15.76	1.72	0.43	0.86	0.29	0.86	0.29	0.00	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	13.57	2.47	2.47	0.00	0.62	0.00	0.62	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	9.08	1.82	0.91	0.00	0.91	0.30	0.30	0.00	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	5.87	1.85	0.62	0.93	0.00	1.23	0.62	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	9.19	3.94	1.31	0.00	0.00	1.31	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	36.20	8.04	0.34	2.35	1.01	1.34	4.02	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	25.19	11.24	1.63	4.35	0.91	1.45	0.54	0.54	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	12.70	3.86	0.80	1.45	1.29	0.80	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	95.15	11.45	3.33	5.34	2.11	3.11	4.56	0.22	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	39.15	4.62	1.32	1.98	2.20	1.87	0.77	0.33	0.55
epididymis, adult	10197-103E8	11.93	4.19	3.35	2.30	1.26	0.63	2.30	0.00	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	16.85	8.34	0.53	3.02	0.35	1.42	0.35	0.00	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.65	3.54	0.79	1.18	0.39	0.39	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	17.95	2.88	0.39	1.31	1.31	0.39	0.13	0.13	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	22.64	4.04	0.98	1.67	1.38	1.08	0.39	0.00	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	20.50	5.15	0.67	1.12	0.90	0.56	0.11	0.00	0.11
esophagus, adult, pool1	10015-101C6	31.11	5.52	2.44	3.29	0.74	0.85	1.38	0.11	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	37.20	14.78	0.63	6.14	1.88	2.76	3.26	0.00	1.13
eye - muscle inferior rectus, donor1	10272-104E2	24.15	7.24	2.41	0.00	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	16.83	2.10	4.21	4.21	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	16.37	5.95	4.46	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	12.61	6.88	2.29	2.29	0.00	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	4.37	1.46	1.46	0.00	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	30.00	11.19	0.25	1.53	0.00	1.53	0.25	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	26.80	4.74	0.90	1.80	1.15	0.64	0.13	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	20.89	4.04	1.19	1.90	1.90	0.47	1.19	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	47.10	17.73	1.69	5.63	7.13	1.41	3.00	0.19	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	26.42	5.10	1.20	2.10	1.50	1.20	2.10	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.29	5.67	0.55	3.11	0.55	0.91	0.73	0.09	0.37
gall bladder, adult	10198-103E9	25.35	6.04	3.38	2.66	0.24	0.97	1.93	0.48	0.97
gamma delta positive T cells, donor1	11937-126A2	32.21	18.25	2.15	4.29	1.61	0.54	0.00	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	28.01	17.55	8.22	5.60	2.61	0.75	0.37	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	24.92	3.38	1.06	2.11	0.84	0.84	0.42	0.00	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	21.08	5.61	0.58	1.55	0.97	1.55	1.55	0.39	0.77
gastric cancer cell line:AZ521	10549-107H9	18.53	4.26	1.64	2.30	1.31	1.64	0.82	0.49	0.00
gastric cancer cell line:GSS	10560-108A2	5.49	5.49	0.00	2.75	5.49	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	23.07	6.63	1.83	1.83	2.51	2.06	2.28	0.23	1.14
giant cell carcinoma cell line:LU65	10487-107B1	8.49	1.84	0.00	0.34	0.46	0.11	0.23	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	28.97	5.18	0.28	2.10	0.56	0.56	0.98	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	29.93	7.98	2.99	2.24	1.25	1.75	0.75	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	32.62	7.07	1.16	2.11	0.53	1.27	0.21	0.11	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	27.81	7.58	1.40	2.25	0.98	0.84	0.56	0.14	0.28
glioblastoma cell line:T98G	10485-107A8	23.40	3.31	0.66	2.10	0.44	0.66	0.11	0.00	0.22
glioma cell line:GI-1	10413-106B8	26.94	5.56	0.00	2.93	1.17	0.59	1.17	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	23.33	2.92	2.92	0.73	2.92	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	41.25	9.52	2.69	2.69	0.73	0.73	0.73	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	20.54	8.22	1.37	0.00	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	35.71	9.59	2.66	1.60	1.07	1.07	1.07	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	137.04	58.73	39.15	14.68	0.00	9.79	0.00	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	10.45	0.00	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	10.88	3.52	0.64	0.96	0.32	1.60	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	14.23	1.84	0.00	0.46	3.67	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	12.35	6.86	0.00	1.37	2.29	0.91	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	7.73	3.22	0.00	1.29	1.29	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	15.81	2.87	0.00	1.44	2.87	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.17	3.43	0.00	1.37	2.06	0.00	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	17.66	14.35	0.00	3.31	5.52	1.10	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	18.96	5.75	6.90	1.72	1.15	0.57	0.29	0.57	0.00
heart - mitral valve, adult	10205-103F7	19.13	4.19	6.28	0.90	0.30	0.60	0.90	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	19.35	6.28	6.80	3.40	1.05	0.52	0.52	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	22.48	9.16	15.82	1.67	1.67	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	21.22	3.67	1.84	1.84	0.41	0.61	0.61	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	27.68	5.54	1.28	0.00	0.85	0.85	2.55	0.00	0.00
heart, adult, pool1	10016-101C7	32.20	5.98	2.53	1.61	0.23	0.92	1.15	0.00	0.23
heart, fetal, pool1	10046-101G1	45.38	10.78	4.72	3.39	1.33	1.54	1.85	0.51	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.65	3.39	0.00	1.54	0.00	1.23	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	10.70	1.19	3.57	0.00	1.19	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	26.74	4.53	0.11	1.44	1.44	0.77	0.00	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	29.74	5.46	0.49	1.70	1.21	1.70	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.44	5.36	0.51	2.32	1.41	1.72	0.10	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	19.02	4.23	0.00	1.11	0.67	0.89	0.56	0.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	16.68	2.81	0.50	2.01	1.11	0.30	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	33.12	12.30	1.89	5.68	1.89	1.89	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	47.96	13.88	0.61	4.49	2.45	1.63	0.41	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	22.41	21.41	0.50	6.47	6.47	2.49	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	29.61	16.92	1.76	3.17	2.11	1.41	2.11	0.00	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	22.58	1.83	1.22	3.05	7.93	1.22	1.22	0.00	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	17.67	3.93	0.00	0.98	3.14	0.39	2.36	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	21.58	5.59	0.25	2.29	2.79	0.76	1.02	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	49.06	10.15	1.69	1.13	1.69	0.00	9.59	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	64.29	9.30	0.52	3.36	2.32	0.26	10.07	0.52	3.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	35.68	7.21	0.00	1.52	1.52	0.00	6.45	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	29.49	6.42	0.58	3.21	0.88	1.75	4.96	0.00	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	35.98	7.76	1.29	3.88	0.65	0.22	5.17	0.22	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	33.78	7.51	0.83	3.34	0.42	1.67	5.42	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	17.52	4.50	0.47	2.13	0.95	0.95	3.08	0.24	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	26.04	6.43	0.48	3.05	0.96	0.64	4.50	0.32	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.24	10.10	1.35	2.02	2.02	2.02	5.39	0.67	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	17.06	4.38	0.16	3.44	2.50	0.00	1.88	0.00	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	18.67	7.86	0.00	1.47	3.44	0.00	1.47	0.00	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	4.36	0.00	2.62	6.11	0.00	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	64.15	10.12	0.19	4.58	2.48	1.15	12.79	0.19	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.92	6.98	0.44	3.92	3.05	0.44	9.59	0.00	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	35.48	5.00	0.00	1.50	3.50	0.00	7.50	0.00	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	26.19	7.16	0.19	2.07	0.57	0.19	3.77	0.00	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.28	7.73	0.00	3.18	0.45	1.36	4.09	0.00	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	26.94	8.77	0.31	1.88	1.57	0.00	5.01	0.00	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.64	4.25	0.65	2.29	0.16	0.00	3.10	0.16	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.58	3.48	0.58	1.74	0.58	0.58	3.48	0.29	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	18.23	5.98	0.00	2.09	1.20	0.00	5.38	0.00	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	21.62	5.17	0.18	3.14	2.96	0.74	0.74	0.00	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	22.82	3.71	0.29	1.43	3.42	0.57	1.14	0.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	27.36	4.90	0.00	1.22	3.67	0.00	2.04	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	39.79	6.34	0.00	2.82	2.11	1.06	5.63	0.00	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	47.83	6.97	0.95	2.53	1.27	0.00	4.75	0.00	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	33.89	7.26	0.00	2.42	2.72	0.00	10.29	0.00	2.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	32.58	7.76	0.00	1.03	0.00	1.03	4.65	0.00	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.89	5.98	0.66	2.66	1.33	0.66	2.66	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.40	4.36	0.00	0.77	0.51	0.51	3.33	0.00	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.62	4.09	0.26	1.02	1.28	0.26	3.07	0.00	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	18.17	7.57	0.00	0.00	0.00	0.00	2.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.82	3.70	1.01	0.67	1.34	1.01	2.35	0.00	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	19.80	5.55	0.48	3.38	4.35	0.48	1.93	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.05	1.78	0.00	4.01	3.57	0.00	0.45	0.00	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	27.32	5.37	0.98	1.95	2.93	0.00	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	44.31	7.95	0.31	3.67	2.44	0.31	7.64	0.00	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	6.51	0.00	0.00	3.25	0.00	16.27	0.00	16.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	26.14	2.65	0.00	2.32	2.65	0.33	10.26	0.00	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.41	10.95	0.55	2.19	0.00	0.55	5.47	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	29.31	3.98	1.09	0.36	0.36	0.72	6.15	0.36	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	33.45	8.19	0.71	1.78	0.71	0.00	4.63	0.00	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	36.99	4.77	0.00	0.00	1.19	0.00	2.39	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	32.37	5.01	0.54	2.84	1.08	1.90	4.47	0.00	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	20.47	4.58	0.54	1.08	0.81	0.27	2.69	0.00	1.35
immature langerhans cells, donor1	11904-125F5	40.92	8.23	2.18	3.15	0.24	1.21	0.00	0.00	0.97
immature langerhans cells, donor2	11905-125F6	28.52	7.13	2.38	1.58	0.79	2.38	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	41.35	15.43	3.22	5.77	7.00	1.23	3.31	0.09	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	8.45	2.60	0.00	0.00	0.65	0.00	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	34.04	6.81	3.50	2.60	1.10	1.40	1.90	0.00	0.40
kidney, fetal, pool1	10045-101F9	29.00	8.28	4.46	2.55	0.71	1.56	1.49	0.28	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	31.39	7.95	2.13	2.27	0.85	2.84	2.13	0.00	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	11.75	2.07	0.00	0.69	0.00	0.28	0.14	0.00	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	35.97	4.22	0.92	1.28	0.92	0.55	0.55	0.00	0.00
left atrium, adult, donor1	10079-102A7	15.80	2.18	1.09	0.54	0.00	0.54	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	10.62	1.52	2.02	0.00	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	12.31	4.38	0.00	1.09	0.82	1.37	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	14.73	1.80	1.44	1.44	2.16	0.36	1.44	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	9.24	1.63	1.09	1.09	0.54	0.54	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	26.95	3.16	0.73	1.21	0.49	1.70	0.73	0.49	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	24.05	3.14	2.09	1.05	3.14	0.00	3.14	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	8.15	2.83	1.65	1.30	0.94	0.71	0.71	0.24	0.35
liposarcoma cell line:KMLS-1	10782-110G8	7.65	1.72	0.00	0.47	0.00	0.47	0.00	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	17.67	4.39	0.73	1.46	0.73	1.10	0.37	0.00	0.12
liver, adult, pool1	10018-101C9	25.28	4.70	2.27	2.59	0.97	1.46	1.30	0.00	0.49
liver, fetal, pool1	10086-102B5	7.53	5.64	0.94	0.00	0.94	0.00	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	46.52	8.90	3.50	2.92	0.87	1.75	0.44	0.15	0.44
locus coeruleus, adult, donor10252	10165-103B3	54.44	9.60	2.40	3.69	1.66	0.92	0.37	0.18	0.92
locus coeruleus, adult, donor10258	10375-105G6	26.52	5.92	3.10	1.69	1.13	1.13	0.85	0.00	1.69
locus coeruleus, newborn, donor10223	10362-105F2	28.60	5.89	5.89	1.68	2.10	2.52	1.68	0.00	2.10
lung adenocarcinoma cell line:A549	10499-107C4	22.84	3.32	0.00	1.66	0.69	0.97	0.42	0.00	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	17.92	4.83	0.00	0.69	0.00	0.00	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	26.63	3.16	2.24	0.92	0.79	1.19	0.66	0.53	0.53
lung, adult, pool1	10019-101D1	40.64	10.16	7.32	2.60	1.18	0.59	1.77	0.00	1.77
lung, fetal, donor1	10068-101I5	39.10	22.26	20.26	2.00	0.57	2.00	1.43	1.14	0.57
lung, right lower lobe, adult, donor1	10075-102A3	24.29	5.04	10.08	1.37	1.83	0.46	0.46	0.92	1.37
lymph node, adult, donor1	10077-102A5	25.56	8.52	3.79	1.42	0.47	0.47	0.00	0.00	1.89
lymphangiectasia cell line:DS-1	10727-110A7	15.56	1.97	1.75	0.88	0.66	1.32	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.15	4.38	5.74	1.66	0.60	0.45	0.30	1.51	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	20.39	4.25	4.25	1.70	0.85	2.55	3.40	0.00	0.85
mature adipocyte, donor1	12231-129F8	31.08	7.10	4.88	3.55	0.44	0.00	2.66	0.44	0.89
mature adipocyte, donor2	12232-129F9	21.17	8.72	10.58	4.36	0.83	0.62	1.25	0.42	0.83
mature adipocyte, donor3	12233-129G1	28.21	9.48	4.98	2.84	0.47	0.71	0.95	0.24	0.24
mature adipocyte, donor4	12234-129G2	38.96	6.32	4.21	3.69	0.53	1.05	0.79	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	21.44	4.77	3.81	2.38	1.43	1.19	1.43	0.71	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	47.38	9.02	1.13	3.38	3.38	2.26	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	54.25	19.68	0.92	6.62	4.78	2.57	1.29	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	24.78	13.34	0.95	3.18	2.86	0.95	0.00	0.32	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	51.61	16.21	0.85	4.69	7.68	1.71	2.56	0.00	5.54
medial temporal gyrus - adult, donor10196	10183-103D3	42.86	12.83	1.01	5.40	4.56	1.52	0.00	0.17	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	61.76	16.77	1.27	6.79	6.37	2.12	0.21	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	42.38	28.89	1.93	3.85	13.48	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	14.35	14.35	43.06	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	42.35	16.87	1.08	6.10	5.03	0.72	1.79	0.00	1.79
medulla oblongata - adult, donor10196	10174-103C3	20.77	4.54	3.89	1.95	0.65	0.65	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	46.44	10.37	2.32	2.79	0.46	0.77	0.15	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	46.20	10.69	2.69	3.35	0.82	2.61	1.55	0.08	0.57
medulla oblongata, newborn, donor10223	10361-105F1	30.20	6.94	1.39	2.78	0.69	0.00	0.00	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	26.79	6.20	1.11	2.21	1.11	0.44	0.66	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	19.44	4.40	0.49	1.22	2.08	1.10	0.24	0.12	0.49
melanoma cell line:COLO 679	10514-107E1	19.84	3.59	1.58	1.87	1.72	1.01	2.30	0.29	1.29
melanoma cell line:G-361	10465-106H6	21.17	3.53	1.90	2.17	0.00	0.27	2.44	0.27	2.17
meningioma cell line:HKBMM	10691-109F7	10.13	1.99	0.36	0.72	0.54	0.18	0.00	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	35.25	4.41	3.52	0.88	3.52	2.64	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	50.29	7.78	0.78	1.81	1.30	2.07	0.78	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.51	2.76	0.31	1.23	0.77	0.31	0.46	0.31	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	11.27	2.54	0.18	0.91	0.55	0.91	0.00	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	15.32	4.14	0.41	1.66	0.83	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.82	1.69	0.56	0.84	0.28	0.98	0.14	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	14.83	2.12	0.00	0.77	0.19	0.77	0.00	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	4.86	0.69	1.39	1.39	2.78	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.84	1.72	0.51	0.00	0.69	0.51	0.51	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	22.89	2.65	0.00	1.15	0.92	0.81	0.46	0.00	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.79	3.32	0.53	0.93	0.80	0.27	0.00	0.13	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.15	2.84	1.35	0.68	0.68	0.68	0.41	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	18.07	1.85	1.00	0.71	0.85	0.57	0.14	0.14	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	9.55	3.62	0.33	1.98	0.66	0.99	2.31	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	19.10	3.46	0.83	1.11	0.28	0.55	0.14	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	14.66	1.40	0.35	1.75	2.09	0.00	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.00	2.25	0.20	0.82	0.20	0.41	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	11.14	4.67	0.72	0.36	1.08	1.08	1.44	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.62	3.21	0.52	0.52	0.41	0.62	0.21	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.00	2.51	1.14	0.91	0.68	0.91	0.23	0.23	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	27.69	2.94	0.84	0.00	0.42	1.26	0.00	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.81	2.69	0.60	0.60	0.60	0.15	0.15	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.21	2.36	0.79	0.96	0.70	0.53	0.18	0.09	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.30	5.52	1.10	2.58	0.00	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.60	3.15	1.14	1.14	0.57	1.43	0.29	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.63	2.11	0.42	1.68	0.84	1.26	0.00	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.33	4.11	0.00	1.37	0.46	0.46	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.25	2.81	0.00	1.79	0.77	0.77	0.00	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	16.49	5.24	0.26	1.57	0.26	1.05	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	17.56	6.47	0.00	2.77	0.92	1.23	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.42	4.24	0.00	1.18	0.94	0.24	0.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.20	3.72	0.00	2.71	0.00	0.68	0.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	17.68	5.11	0.00	0.79	0.79	0.79	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.90	6.95	0.46	1.39	0.00	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.90	5.19	0.00	1.15	0.29	0.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.83	4.91	0.22	2.23	0.00	0.22	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.82	4.33	0.00	0.24	1.20	0.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	12.47	4.40	0.73	1.47	0.73	1.47	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.40	4.70	0.34	1.34	0.00	0.34	0.67	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.10	6.14	0.00	1.23	0.00	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.75	6.44	0.43	1.29	2.15	0.43	0.43	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	5.47	0.00	0.00	0.00	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	11.69	2.27	0.00	0.97	0.32	0.32	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	2.91	0.00	0.00	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	2.13	2.13	2.13	0.53	0.00	0.00	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	2.45	0.00	1.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.44	4.28	0.00	0.39	0.78	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	4.20	0.00	0.00	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	3.97	0.00	0.00	0.99	0.00	0.00	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.30	3.56	0.00	0.00	0.00	0.59	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	2.44	0.00	2.44	1.22	1.22	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	3.17	0.63	0.63	0.63	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.73	3.45	0.34	0.34	0.00	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	4.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.96	2.44	0.41	0.00	0.41	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	0.79	0.00	0.00	0.00	0.79	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	4.13	0.00	0.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	4.36	0.31	0.31	0.00	0.62	0.00	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	2.67	0.00	0.00	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	5.91	0.00	0.00	0.00	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	10.27	0.00	0.00	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.70	1.38	0.00	1.38	0.00	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.33	1.98	0.99	0.99	1.48	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	6.73	1.12	1.12	0.00	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	1.27	0.00	1.27	0.00	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	12.09	2.42	0.81	1.61	0.00	0.00	0.81	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	10.90	0.00	4.36	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	1.27	1.27	0.00	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	16.99	1.82	0.00	0.61	0.61	1.21	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	13.18	4.12	0.82	1.65	0.00	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	14.29	3.57	0.60	1.39	0.20	0.79	0.20	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.22	4.87	0.32	1.30	0.65	0.97	0.00	0.00	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	3.06	0.00	1.02	1.02	0.00	0.00	0.00	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	5.42	3.09	0.00	0.00	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.72	4.72	0.00	1.18	0.71	0.94	0.24	0.00	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	28.50	3.48	3.24	3.71	0.70	0.93	0.00	0.46	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	0.00	4.27	0.00	0.00	0.00	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	16.44	2.16	0.72	0.82	0.62	0.00	0.31	0.10	0.31
mesothelioma cell line:Mero-25	10850-111F4	13.16	3.63	1.36	1.36	1.13	0.68	0.23	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	23.96	6.85	1.22	2.69	1.47	1.22	0.49	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	24.80	3.76	0.00	0.66	0.00	1.33	0.00	0.00	0.44
mesothelioma cell line:Mero-82	10853-111F7	23.39	4.20	1.31	1.05	1.05	0.79	0.26	0.26	1.05
mesothelioma cell line:Mero-83	10854-111F8	18.55	4.43	1.19	1.53	1.70	1.02	0.85	0.00	0.51
mesothelioma cell line:Mero-84	10855-111F9	29.32	6.57	0.00	1.77	0.76	0.76	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	21.53	8.49	0.62	1.45	1.86	0.41	0.21	0.21	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	31.14	3.81	1.49	1.33	0.66	0.83	0.17	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	17.92	4.52	2.35	1.09	0.72	1.27	0.18	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	21.69	5.30	1.71	2.90	0.34	0.51	0.17	0.34	0.34
mesothelioma cell line:NCI-H28	10845-111E8	20.87	2.80	0.00	1.27	0.76	1.02	0.25	0.00	0.25
mesothelioma cell line:No36	10857-111G2	28.05	4.57	0.98	2.94	0.98	0.33	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	41.73	5.69	1.35	0.81	0.00	1.08	0.54	0.00	0.81
migratory langerhans cells, donor1	11901-125F2	23.61	6.72	0.19	1.15	0.58	0.96	0.00	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	20.27	5.13	0.12	3.05	0.61	1.10	0.00	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	25.49	5.20	1.97	2.69	0.36	0.36	0.18	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	22.53	1.31	1.31	0.33	2.29	0.65	0.98	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.69	1.91	0.21	1.27	0.64	1.06	0.00	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	40.77	4.84	0.46	1.15	1.61	2.07	0.46	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.70	4.00	1.52	1.71	1.52	0.38	0.38	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	20.70	5.17	1.66	3.70	0.55	0.92	0.37	0.00	0.92
myeloma cell line:PCM6	10474-106I6	20.95	6.13	2.17	2.77	0.00	0.20	0.79	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	14.71	1.01	1.01	1.52	0.51	0.51	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	9.41	4.71	2.16	0.98	0.78	0.00	0.39	0.20	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	32.31	4.90	0.22	1.34	1.34	1.45	0.11	0.00	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	32.95	4.41	0.37	2.06	1.03	1.54	0.22	0.00	0.29
nasal epithelial cells, donor2	12227-129F4	45.82	5.52	1.10	2.21	3.31	3.86	0.55	0.00	1.66
neuroblastoma cell line:CHP-134	10508-107D4	57.75	10.12	0.23	0.69	2.07	2.76	0.92	0.00	1.38
neuroblastoma cell line:NB-1	10539-107G8	40.04	8.61	0.94	3.37	2.81	3.37	0.19	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	10.76	2.74	0.84	0.84	0.21	0.63	0.63	0.00	0.63
neuroblastoma cell line:NH-12	10555-107I6	40.07	8.76	1.49	1.12	0.56	0.75	1.30	0.00	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	11.15	4.98	0.47	0.47	0.00	0.24	0.47	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	10.14	3.33	0.00	0.48	0.95	0.32	1.74	0.00	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	19.72	4.23	0.20	1.81	0.81	0.00	0.20	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.70	5.72	0.64	0.64	0.64	0.64	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	11.18	4.26	0.00	0.80	0.80	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	223.12	29.75	14.87	14.87	14.87	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	13.28	0.00	0.00	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	14.71	7.27	3.55	3.21	1.01	0.17	0.68	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.02	4.80	0.00	0.80	1.60	0.80	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.85	3.21	1.60	1.28	0.00	0.96	0.32	0.32	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	27.59	4.73	0.26	1.31	0.00	0.26	0.00	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	41.62	12.47	1.97	3.56	6.94	1.31	3.56	0.19	0.75
occipital cortex - adult, donor10196	10172-103C1	43.27	8.24	2.06	4.12	8.24	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	60.38	13.15	3.49	3.76	3.22	1.88	1.07	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	52.04	26.57	1.46	5.82	5.46	1.09	1.82	0.00	1.82
occipital lobe, adult, donor1	10076-102A4	33.06	7.61	1.31	2.89	5.51	0.52	3.94	0.00	1.31
occipital lobe, fetal, donor1	10073-102A1	41.19	12.87	2.15	5.58	0.00	2.57	2.57	0.00	1.29
occipital pole, adult, pool1	10036-101E9	48.72	17.19	1.18	5.52	5.60	1.50	2.13	0.08	0.24
olfactory region, adult	10195-103E6	43.56	13.95	1.34	4.97	8.22	1.53	0.19	0.00	0.00
optic nerve, donor1	10277-104E7	14.01	4.00	2.00	4.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.86	3.76	1.25	1.82	0.34	1.71	2.39	0.11	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	15.52	4.26	0.41	1.37	0.69	0.69	0.00	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	50.80	6.43	2.03	1.52	1.69	1.86	0.51	0.51	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	10.86	3.35	2.54	0.81	1.04	1.73	0.35	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	27.63	7.06	1.18	2.06	1.18	2.06	0.88	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	0.93	4.67	0.93	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	12.94	4.03	0.85	2.12	0.85	1.06	1.27	0.00	0.42
ovary, adult, pool1	10020-101D2	25.24	8.74	3.67	2.88	1.48	0.52	0.44	0.26	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.50	2.20	0.18	0.37	0.73	0.37	0.37	0.00	0.18
pancreas, adult, donor1	10049-101G4	13.17	6.58	0.00	0.00	0.00	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	34.38	5.03	0.84	2.24	4.47	1.40	3.35	0.56	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	37.65	5.96	4.94	1.19	0.85	1.53	0.85	0.68	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	36.43	6.46	1.32	1.49	0.99	1.49	0.99	0.00	1.16
paracentral gyrus, adult, pool1	10035-101E8	49.15	15.38	1.92	5.03	9.70	1.83	2.56	0.18	0.64
parietal cortex, adult, donor10258	10373-105G4	26.42	14.68	1.47	2.20	8.07	2.20	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	43.26	10.35	2.82	0.00	1.88	1.88	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	60.71	12.26	1.43	5.70	3.71	2.85	0.57	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	58.86	17.36	2.38	6.43	7.75	2.64	2.47	0.00	0.62
parietal lobe, fetal, donor1	10072-101I9	70.80	20.37	0.97	0.00	3.88	0.97	2.91	0.00	5.82
parietal lobe, newborn, donor10223	10356-105E5	40.38	20.56	2.62	7.10	5.98	1.12	1.50	0.37	2.99
parotid gland, adult	10199-103F1	26.52	6.78	3.08	3.08	0.00	0.00	0.62	1.85	0.62
penis, adult	10200-103F2	14.50	3.76	4.30	1.07	0.54	0.54	2.15	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	12.46	2.42	0.00	0.93	0.00	0.00	0.56	0.00	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	28.12	4.95	1.02	2.48	1.02	1.02	0.29	0.29	0.73
pineal gland - adult, donor10196	10179-103C8	47.09	15.48	1.94	5.16	0.65	1.94	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	76.40	22.50	0.00	6.51	1.78	2.96	1.18	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	28.85	11.91	0.63	1.25	2.51	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	56.66	17.20	1.01	1.01	2.02	2.02	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	83.39	22.41	4.69	5.21	2.08	4.17	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	26.39	9.36	0.00	3.40	1.70	1.70	0.00	0.85	1.70
placenta, adult, pool1	10021-101D3	46.33	9.46	5.91	3.33	0.65	2.90	0.97	0.75	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	14.70	4.11	0.66	1.32	0.40	0.13	0.40	0.00	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	33.15	9.03	0.78	2.18	0.47	0.93	0.78	0.00	0.62
pons, adult, pool1	10033-101E6	37.27	11.10	1.89	2.84	1.72	3.10	4.22	0.43	0.69
postcentral gyrus, adult, pool1	10032-101E5	40.71	14.73	1.57	5.06	7.32	1.74	4.97	0.26	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	56.47	18.82	37.65	6.27	4.18	4.18	0.00	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	25.93	2.18	0.87	1.02	0.73	0.58	0.00	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	47.55	6.90	0.73	2.90	2.00	1.63	0.36	0.00	0.36
prostate, adult, pool1	10022-101D4	27.03	8.98	2.90	3.81	0.73	1.18	1.00	0.18	0.18
putamen, adult, donor10196	10176-103C5	58.07	14.64	1.42	6.37	5.67	1.89	0.24	0.00	0.24
putamen, adult, donor10252	10152-102I8	39.21	7.84	0.00	0.00	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	14.21	1.09	1.09	5.46	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	34.79	12.56	2.17	3.14	7.01	1.69	0.72	0.00	0.00
putamen, newborn, donor10223	10365-105F5	20.24	2.25	0.75	5.25	0.75	0.75	0.00	0.00	3.00
rectal cancer cell line:TT1TKB	10469-106I1	16.29	2.33	0.58	1.16	0.87	1.75	1.16	0.00	0.58
rectum, fetal, donor1	10067-101I4	29.21	4.17	8.35	2.78	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	4.66	1.48	0.00	0.42	0.00	0.00	0.42	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.94	2.90	0.00	3.73	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	36.88	11.73	3.38	2.88	1.19	1.59	3.28	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	21.56	5.20	0.00	2.60	1.30	0.00	1.30	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	8.48	3.93	0.37	0.86	1.23	0.25	0.61	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	34.59	7.31	0.28	1.12	0.56	0.84	0.28	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	4.55	0.76	0.00	0.00	0.00	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	18.13	3.88	0.81	1.46	0.49	1.13	1.46	0.16	0.81
salivary acinar cells, donor2	11772-123I8	31.39	6.47	0.83	2.62	0.28	1.38	2.62	0.00	2.62
salivary acinar cells, donor3	11773-123I9	37.74	6.62	3.97	1.99	0.00	0.66	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	45.18	6.29	4.00	2.29	2.86	0.57	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.76	6.66	0.59	3.71	0.59	1.10	0.42	0.08	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	19.40	4.58	0.59	2.47	0.82	1.06	0.59	0.00	0.59
seminal vesicle, adult	10201-103F3	9.52	2.65	2.65	0.00	0.00	0.53	2.12	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	25.26	4.37	0.97	1.46	0.97	0.97	0.24	0.00	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	21.39	3.52	0.50	1.26	1.01	0.25	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	35.12	3.01	1.00	3.01	0.00	0.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	16.25	3.63	0.27	1.48	0.54	0.40	0.13	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	14.26	1.99	0.99	1.33	0.77	0.88	0.55	0.33	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	22.45	4.77	0.39	1.42	0.77	0.52	0.26	0.00	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	12.77	2.84	0.71	0.71	0.71	0.00	0.71	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	43.18	6.48	4.20	2.16	0.60	0.60	1.20	0.60	0.72
skeletal muscle, fetal, donor1	10066-101I3	9.05	3.02	0.00	1.01	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	7.57	6.31	0.00	1.89	0.00	0.00	0.63	1.26	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	26.01	4.34	2.00	1.67	3.67	1.67	1.00	0.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	48.54	7.88	2.21	3.47	2.52	4.10	1.26	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	29.49	9.06	0.77	4.24	1.54	0.39	0.19	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	35.11	5.44	4.45	1.98	0.82	1.15	0.16	0.82	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	41.66	6.27	0.16	2.09	2.57	0.00	0.48	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	56.22	10.90	5.88	2.83	0.87	4.36	2.62	1.31	1.96
small intestine, adult, pool1	10024-101D6	47.78	9.79	2.51	5.26	0.96	2.27	3.58	0.36	0.24
small intestine, fetal, donor1	10064-101I1	18.18	5.41	0.98	1.97	1.23	0.25	0.74	0.25	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.90	2.05	2.56	0.51	0.51	1.03	2.56	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	15.25	4.65	2.84	1.55	0.52	0.00	0.78	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	18.76	4.56	0.80	1.07	0.54	0.80	0.27	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	30.28	6.65	1.38	2.29	0.46	1.38	0.23	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	40.22	10.65	0.39	2.37	0.79	1.18	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	16.60	6.92	0.69	2.08	0.69	1.38	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	37.20	9.15	2.44	4.27	1.22	1.22	3.05	0.00	2.44
spinal cord, newborn, donor10223	10359-105E8	39.49	6.89	2.30	2.76	1.84	0.46	0.46	0.92	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.34	3.88	0.75	1.64	1.19	1.34	0.00	0.00	0.30
spleen, adult, pool1	10025-101D7	38.88	14.76	16.19	2.86	0.66	1.10	1.76	1.32	1.43
spleen, fetal, pool1	10044-101F8	24.55	8.90	18.59	2.62	1.11	1.03	2.62	1.43	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.11	3.21	0.83	1.97	1.14	0.41	0.31	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.65	3.61	0.38	1.71	0.76	0.57	0.76	0.19	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.27	5.59	1.05	1.05	0.35	0.70	0.35	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	12.51	0.39	1.17	0.78	1.17	0.78	0.00	0.00	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	64.50	8.55	1.69	2.36	1.01	5.74	0.56	0.11	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	8.90	3.39	0.00	0.42	0.85	1.27	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	13.12	4.23	2.12	2.12	0.00	1.27	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	14.95	3.20	3.20	1.07	0.00	0.00	2.14	1.07	0.00
submaxillary gland, adult	10202-103F4	25.07	6.84	2.28	1.14	0.57	1.14	2.28	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	54.27	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	36.14	9.14	2.28	3.95	0.21	1.04	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	21.21	17.07	2.59	3.10	0.52	3.10	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	30.38	7.77	1.41	4.24	0.00	0.71	0.71	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	23.61	4.59	0.23	2.06	0.46	0.69	0.92	0.23	0.69
temporal lobe, adult, pool1	10031-101E4	43.49	16.11	1.70	5.85	7.80	1.70	2.80	0.00	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	55.56	25.64	1.42	6.41	0.71	2.85	0.71	0.00	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	55.82	43.07	2.64	7.03	2.20	3.52	1.32	0.00	2.20
tenocyte, donor1	11763-123H8	20.95	4.89	0.70	2.09	0.35	0.70	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	14.88	4.58	0.00	1.53	0.38	0.00	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	14.09	4.82	0.00	2.22	0.37	1.11	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	15.13	3.91	0.17	1.02	2.04	0.68	0.17	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	10.94	3.24	0.46	0.62	1.85	0.62	1.23	0.00	0.62
teratocarcinoma cell line:PA-1	10807-111A6	12.24	3.41	0.77	1.08	1.39	1.08	0.31	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	18.15	3.30	0.63	1.14	4.19	0.76	1.14	0.13	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	12.86	4.54	0.00	0.38	3.78	1.13	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.74	1.42	0.22	0.11	1.42	0.22	1.09	0.11	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	12.05	1.63	0.33	1.63	0.98	0.65	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	27.27	11.81	2.79	4.51	5.80	1.18	1.18	0.11	1.18
testis, adult, pool2	10096-102C6	24.36	12.63	0.45	5.86	16.24	1.80	0.90	0.00	0.45
thalamus - adult, donor10196	10168-103B6	39.74	6.62	1.10	2.21	0.00	1.10	0.00	1.10	3.31
thalamus, adult, donor10252	10154-103A1	44.38	8.75	2.03	3.59	1.41	1.09	0.47	0.00	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	18.48	1.54	4.62	3.08	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.59	5.76	0.49	1.81	0.16	0.66	0.16	0.33	0.33
thalamus, newborn, donor10223	10366-105F6	35.67	3.45	1.15	2.88	0.00	1.73	1.15	0.00	0.58
throat, adult	10209-103G2	15.73	5.74	2.50	1.50	1.25	0.50	1.50	0.25	0.00
throat, fetal, donor1	10061-101H7	35.96	7.92	2.44	3.05	0.61	0.61	0.30	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	8.35	6.36	0.00	1.79	0.00	0.40	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	112.24	22.87	2.39	7.16	1.69	3.68	2.98	0.00	1.89
thymus, fetal, pool1	10043-101F7	72.94	15.79	4.88	4.78	1.56	2.08	8.21	0.52	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	14.23	3.86	0.27	1.46	0.80	0.53	0.66	0.00	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	23.19	3.91	0.98	0.98	0.98	0.84	0.14	0.00	0.28
thyroid, adult, pool1	10028-101E1	31.82	9.24	1.96	1.59	0.28	0.65	0.65	0.09	0.28
thyroid, fetal, donor1	10060-101H6	27.95	4.75	5.80	2.37	0.53	1.58	0.26	0.00	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	3.08	6.16	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	13.26	3.72	3.49	1.16	0.47	0.93	1.16	0.23	0.23
tongue, fetal, donor1	10059-101H5	16.95	2.76	3.55	1.18	0.39	1.18	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	18.43	5.21	2.50	1.40	0.70	0.30	1.70	0.40	0.20
trachea, adult, pool1	10029-101E2	29.37	6.79	3.93	1.72	0.65	1.06	0.74	0.16	0.25
trachea, fetal, donor1	10058-101H4	26.16	8.46	1.92	0.77	0.38	0.38	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.46	3.54	0.35	0.71	0.35	0.71	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	30.70	5.57	2.63	1.52	1.32	2.43	0.91	0.30	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	27.58	5.64	1.10	3.92	1.88	0.63	3.45	0.00	1.57
tridermal teratoma cell line:HGRT	10694-109G1	17.12	1.90	1.90	0.00	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.00	2.54	0.42	0.85	0.08	0.00	0.25	0.00	0.34
umbilical cord, fetal, donor1	10057-101H3	20.87	8.35	2.09	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	32.42	10.41	8.36	1.71	1.37	0.85	1.54	0.34	0.51
uterus, fetal, donor1	10055-101H1	19.97	8.19	1.54	1.02	0.00	1.54	0.00	0.00	0.00
vagina, adult	10204-103F6	23.91	5.17	10.34	3.23	1.29	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	21.48	8.33	4.60	2.19	0.66	0.88	1.10	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.88	4.01	1.07	1.07	0.80	0.80	0.00	0.00	0.27